267 INVITED Personalised Therapy in Breast Cancer (English)
- New search for: Linn, S.
- New search for: Linn, S.
In:
EUROPEAN JOURNAL OF CANCER
;
47
;
S62
;
2011
-
ISSN:
- Article (Journal) / Print
-
Title:267 INVITED Personalised Therapy in Breast Cancer
-
Contributors:Linn, S. ( author )
-
Published in:EUROPEAN JOURNAL OF CANCER ; 47 ; S62
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam.
-
Publication date:2011-01-01
-
Size:S62
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.994
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.994 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 47
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
New therapeutic avenues in lung cancer based on disturbances in PI3K and RAS pathwaysRosell, R. et al. | 2011
- 1
-
The requirements of a specialist Prostate Cancer Unit: A discussion paper from the European School of OncologyValdagni, R. / Albers, P. / Bangma, C. / Drudge-Coates, L. / Magnani, T. / Moynihan, C. / Parker, C. / Redmond, K. / Sternberg, C. N. / Denis, L. et al. | 2011
- 1
-
Adjuvant Systemic Treatment for Women with Breast Cancer: The Future of Clinical TrialsGoldhirsch, A. / Gelber, R. et al. | 2011
- 2
-
VANTAGE 014: Vorinostat (V) in Patients With Advanced Malignant Pleural Mesothelioma (MPM) who Have Failed Prior Pemetrexed and Either Cisplatin or Carboplatin Therapy: A Phase III, Randomized, Double-Blind, Placebo-Controlled TrialKrug, L. M. / Kindler, H. / Calvert, H. / Manegold, C. / Tsao, A. S. / Fennell, D. / Lubiniecki, G. M. / Sun, X. / Smith, M. / Baas, P. et al. | 2011
- 2
-
Synchronous Chemo-radiation Can Reduce Local Recurrence in Early Stage Breast Cancer: Results of the SECRAB Trial (ISRCTN: 84214355) Presented on Behalf of the SECRAB Steering CommitteeFernando, I. / Bowden, S. J. / Brookes, C. L. / Grieve, R. / Spooner, D. / Agrawal, R. K. / Brunt, A. M. / Churn, M. / Rea, D. W. / Canney, P. et al. | 2011
- 2
-
A Pivotal Multicenter Trial Evaluating Efficacy and Safety of the Hedgehog Pathway Inhibitor (HPI) Vismodegib in Patients With Advanced Basal Cell Carcinoma (BCC)Dirix, L. / Migden, M. R. / Oro, A. E. / Hauschild, A. / Lewis, K. / Mueller, A. B. / Yauch, R. / Reddy, J. C. / Sekulic, A. et al. | 2011
- 3
-
Blood Pressure and Risk of Incident and Fatal Cancer in the Metabolic Syndrome and Cancer Project (Me-Can) - Analysis of Seven Prospective CohortsVan Hemelrijck, M. / Stocks, T. / Jonsson, H. / Manjer, J. / Ulmer, H. / Bjorge, T. / Stattin, P. et al. | 2011
- 3
-
Overall Survival Benefit of Radium-223 Chloride (Alpharadin) in the Treatment of Patients with Symptomatic Bone Metastases in Castration-resistant Prostate Cancer (CRPC): a Phase III Randomized Trial (ALSYMPCA)Parker, C. / Heinrich, D. / OSullivan, J. M. / Fossa, S. / Chodacki, A. / Demkow, T. / Cross, A. / Bolstad, B. / Garcia-Vargas, J. / Sartor, O. et al. | 2011
- 4
-
Laparoscopic Surgery Versus Open Surgery for Rectal Cancer: Short-term Outcomes of a Randomised TrialBonjer, H. J. / Haglind, E. / Cuesta, M. A. / Furst, A. / Lacy, A. / van der Pas, M. H. / Hop, W. C. et al. | 2011
- 4
-
Everolimus in Subependymal Giant Cell Astrocytomas (SEGA) Associated with Tuberous Sclerosis Complex (TSC): Results of EXIST-1, a Double-Blind Placebo-controlled Phase III TrialBebin, M. / Franz, D. N. / Sahmoud, T. / Belousova, E. / Sparagana, S. / Frost, M. / Ford, J. / Shah, G. / Cauwel, H. / Jozwiak, S. et al. | 2011
- 4
-
Very Accelerated Radiotherapy (RT) Versus Concomitant Chemo-Radiotherapy (Ct-Rt) In Locally Advanced Head And Neck Cancer: Long Term Results From 2 Phases III GORTEC Randomized TrialsBourhis, J. / Sire, C. / Graff, P. / Gregoire, V. / Maingon, P. / Lapeyre, M. / Tortochaux, J. C. / Gery, B. / Martin, L. / Alfonsi, M. et al. | 2011
- 5
-
Efficacy in Patient Subgroups in OCEANS, a Randomized, Double-blinded, Placebo-controlled, Phase 3 Trial of Chemotherapy +- Bevacizumab in Patients with Platinum-sensitive Recurrent Epithelial Ovarian (OC), Primary Peritoneal (PPC), or Fallopian Tube Cancer (FTC)Aghajanian, C. / Blank, S. V. / Goff, B. / Judson, P. L. / Makhija, S. / Sharma, S. K. / Nycum, L. R. / Yi, J. / Husain, A. et al. | 2011
- 5
-
Results From VELOUR, a Phase 3 Study of Aflibercept (A) Versus Placebo (pbo) in Combination with FOLFIRI for the Treatment of Patients (pt) with Previously Treated Metastatic Colorectal Cancer (MCRC)Tabernero, J. / Van Cutsem, E. / Lakomy, R. / Prausova, J. / Ruff, P. / Van Hazel, G. / Moiseyenko, V. / Ferry, D. / McKendrick, J. / Soussan-Lazard, K. et al. | 2011
- 6
-
A Multicentre Randomised Trial of Ibandronate Compared to Single Dose Radiotherapy for Localised Metastatic Bone Pain in Prostate Cancer (RIB)Hoskin, P. / Sundar, S. / Reczko, K. / Forsyth, S. / Mithal, N. / Sizer, B. / Toy, L. / Stratford, M. / Jitlal, M. et al. | 2011
- 6
-
Everolimus in Combination with Exemestane for Postmenopausal Women with Advanced Breast Cancer Who Are Refractory to Letrozole or Anastrozole: Results of the BOLERO-2 Phase III TrialBaselqa, J. / Campone, M. / Sahmoud, T. / Piccart, M. / Burris, H. / Rugo, H. / Noguchi, S. / Gnant, M. / Mukhopadhyay, P. / Hortobagyi, G. et al. | 2011
- 6
-
Delivering Affordable Cancer Care in High-income Countries: a Lancet Oncology CommissionSullivan, R. / Peppercorn, J. / Sikora, K. / Zalcberg, J. / Meropol, N. / Amir, E. / Khayat, D. / Boyle, P. / Tannock, I. / Fojo, T. et al. | 2011
- 7
-
The EORTC 10041/BIG 03-04 MINDACT (Microarray in Node Negative and 1 to 3 Positive Lymph Node Disease May Avoid ChemoTherapy) Trial: Patients Baseline Characteristics and Logistics Aspects After a Successful AccrualPiccart, M. / Bogaerts, J. / Cardoso, F. / Werutsky, G. / Delaloge, S. / Van t Veer, L. / Rubio, I. / Moulin, C. / Engelen, K. / Viale, G. et al. | 2011
- 7
-
Identification of Novel Somatic Mutations in SF3B1, a Gene Encoding a Core Component of RNA Splicing Machinery, in Myelodysplasia with Ring Sideroblasts and Other Common CancersPapaemmanuil, E. / Malcovati, L. / Cazzola, M. / Hellstrom-Lindberg, E. / Bowen, D. / Boultwood, J. B. / Green, A. R. / Futreal, P. A. / Stratton, M. R. / Campbell, P. J. et al. | 2011
- 8
-
Cognitive and Cardiac Outcome After Prenatal Exposure to Chemotherapy in Children 18 Months or OlderAmant, F. / Van Calsteren, K. / Halaska, M. / Mhallem, M. / Lagae, L. / Willemsen, M. / Kapusta, L. / Van Calster, B. / Mertens, L. / Ottevanger, P. et al. | 2011
- 8
-
Efficacy of Veliparib (ABT-888) Plus Temozolomide Versus Temozolomide Alone: a Randomized, Double-blind, Placebo-controlled Trial in Patients with Metastatic MelanomaMiddleton, M. / Friedlander, P. / Hamid, O. / Daud, A. / Plummer, R. / Schuster, R. / Qian, J. / Luo, Y. / Giranda, V. / McArthur, G. et al. | 2011
- 8
-
A Phase l/lI, Open-label, Randomised Study of BIBF 1120 Plus mFOLFOX6 Compared to Bevacizumab Plus mFOLFOX6 in Patients with Metastatic Colorectal CancerVan Cutsem, E. / Prenen, H. / Guillen-Ponce, C. / Bennouna, J. / Di Benedetto, M. / Bouche, O. / Staines, H. / OumHamed, Z. / Studeny, M. / Capdevila, J. et al. | 2011
- 8
-
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumoursAapro, M. S. / Bohlius, J. / Cameron, D. A. / Lago, L. D. / Donnelly, J. P. / Kearney, N. / Lyman, G. H. / Pettengell, R. / Tjan-Heijnen, V. C. / Walewski, J. et al. | 2011
- 9
-
Drugging the Undruggable Small-molecule Inhibition of Ras OncoproteinFang, G. / Maurer, T. / Garrenton, L. / Skelton, N. / Fauber, B. / Malek, S. / Giannetti, A. / Jackson, P. / Rudolph, J. / Wang, W. et al. | 2011
- 9
-
Reversal of Tamoxifen Resistance (Hormone Resistance) by Addition of Sirolimus (mTOR Inhibitor) in Metastatic Breast CancerBhattacharvva, G. S. / Biswas, J. / Singh, J. K. / Singh, M. / Govindbabu, K. / Ranade, A. A. / Malhotra, H. / Parikh, P. M. / Shahid, T. / Basu, S. et al. | 2011
- 10
-
A Double-blind, Randomized Phase lib Study Evaluating the Efficacy and Safety of Sorafenib (SOR) Compared to Placebo (PL) When Administered in Combination with Docetaxel And/or Letrozole in Patients with Metastatic Breast Cancer (MBC): FM-B07-01 TrialMariani, G. / Burdaeva, O. / Roman, L. / Staroslawska, E. / Udovitsa, D. / Driol, P. / Goisis, G. / Zamagni, C. / Semiglazov, V. / Gianni, L. et al. | 2011
- 10
-
Clinical, Molecular, and Molecular-Clinical Profile (MCP) Exploratory Subset Analysis of RTOG 0525: a Phase III Trial Comparing Standard (std) Adjuvant Temozolomide (TMZ) with a Dose-dense (dd) Schedule for Glioblastoma (GBM)Mehta, M. / Wang, M. / Aldape, K. / Sulman, E. / Stupp, R. / Jaeckle, K. / Blumenthal, D. / Erridge, S. / Curran, W. / Gilbert, M. et al. | 2011
- 11
-
Escalated-dose Conformai Radiotherapy for Localised Prostate Cancer: Long-term Overall Survival Results From the MRC RT01 Randomised Controlled TrialDearnaley, D. P. / Jovic, G. / Syndikus, I. / Graham, J. D. / Aird, E. G. / Khoo, V. / Cowan, R. / Sydes, M. R. et al. | 2011
- 11
-
Celecoxib Plus Hormone Therapy Vs Hormone Therapy Alone for Hormone-sensitive Prostate Cancer: First Results From the STAMPEDE Randomised Controlled Trial (MRC PR08)James, N. D. / Svdes, M. R. / Mason, M. D. / Clarke, N. W. / Dearnaley, D. P. / Dwyer, J. / Jovic, G. / Russell, J. M. / Thalmann, G. / Parmar, M. K. et al. | 2011
- 11
-
A Phase 2b, Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Sorafenib (SOR) Compared With Placebo (PBO) When Administered in Combination With Chemotherapy (Modified FOLFOX6) for First-line Treatment (tx) of Patients (Pts) With Metastatic Colorectal Cancer (mCRC). The RESPECT TrialTabernero, J. / Garcia-Carbonero, R. / Konne, C. H. / ODwyer, P. J. / Sobrero, A. / Van Cutsem, E. / Gladkov, O. / Davidenko, I. / Salazar, R. / Cassidy, J. et al. | 2011
- 12
-
Quality of Life in the ICON7 GCIG Phase III Randomised Clinical TrialStark, D. / Nankivell, M. / Hilpert, F. / Elit, L. / Brown, J. / Lanceley, A. / Valikova, G. / Oza, A. / Swart, A. M. / Perren, T. et al. | 2011
- 12
-
Mutation and Protein Expression Biomarkers Correlate with Response to AKT Inhibition in a Phase I Trial of the Oral Pan AKT Inhibitor GSK2141795 (GSK795) in Patients (pts) with Platinum Resistant Ovarian CancerGunqor, H. / Stronach, E. / Curry, E. / Saleem, A. / Agarwal, R. / Blagden, S. / Babar, S. / Mills, G. / Morris, S. R. / Gabra, H. et al. | 2011
- 12
-
Quality of Life Outcomes of a Randomized, Placebo-Controlled Trial of Bevacizumab in the Front-Line Treatment of Ovarian Cancer: a Gynecologic Oncology Group StudyMonk, B. J. / Huang, H. / Burger, R. A. / Mannel, R. L. / Homesley, H. D. / Fowler, J. / Greer, B. E. / Boente, M. / Liang, S. X. / Wenzel, L. et al. | 2011
- 13
-
Results of a Pilot External Quality Assurance Scheme for Somatic EGFR Mutation Testing in Non-Small Cell Lung Cancer Managed by EMQN, ESMO, ESP, and ETOPNormanno, N. / Patton, S. / Murray, S. / Blackhall, F. / Kerr, K. M. / Dietel, M. / Filipits, M. / Taron, M. / Stahel, R. / Thunnissen, E. et al. | 2011
- 13
-
Safety and Efficacy of Panitumumab (pmab) in HPV Positive (+) and HPV Negative (-) Recurrent/metastatic (R/M) Squamous Cell Carcinoma of the Head and Neck (SCCHN): Analysis of the Phase 3 SPECTRUM TrialVermorken, J. / Stohlmacher, J. / Oliner, K. / Villanueva, C. / Foa, P. / Winquist, E. / Licitra, L. / Skladowski, K. / Pan, Z. / Bach, B. A. et al. | 2011
- 14
-
Vemurafenlb Improves Overall Survival Compared to Dacarbazlne In Advanced BRAFV600E-mutated Melanoma: Updated Survival Results From a Phase III Randomised, Open-label, Multlcentre TrialMcArthur, G. / Hauschild, A. / Robert, C. / Haanen, J. B. / Ascierto, P. / Lee, R. J. / Nolop, K. / Nelson, B. / Flaherty, K. T. / Chapman, P. B. et al. | 2011
- 14
-
Unrecognised and Underprepared: an Exploratory Mixed Method Study of Informal Carers Experiences of Supporting Someone Through ChemotherapyReam, E. / Pedersen, V. / Oakley, C. / Richardson, A. / Taylor, C. / Verity, R. et al. | 2011
- 14
-
A Phase II Study of Sorafenlb In Patients with Locally Advanced And/or Metastatic (stage 1MB or IV) Non-small Cell Lung Cancer (NSCLC) with a K-Ras MutationDinqemans, A. M. / Mellema, W. W. / Groen, H. J. / van Wijk, A. / Burgers, S. / Kunst, P. W. / Thunnissen, F. B. / Heideman, D. A. / Smit, E. F. et al. | 2011
- 15
-
Denosumab Treatment for Giant Cell Tumor of Bone (GCTB) in Adolescent Patients: Interim Results From a Phase II StudyEnqellau, J. / Chawla, S. / Grimer, R. / Powell, A. / Schuetze, S. / Skubitz, K. / Staddon, A. / Atchison, C. / Zhao, Y. / Jacobs, I. et al. | 2011
- 15
-
A Randomized Clinical Trial of Adjuvant Chemotherapy with Doxorubicin, Ifosfamide, and Cisplatin in Localized Uterine Sarcomas. Results On 81 Randomized PatientsPautier, P. / Floquet, A. / Gladieff, L. / Berton-Rigaud, D. / Piperno-Neumann, S. / Selle, F. / Guillemet, C. / Weber, B. / Rey, A. et al. | 2011
- 15
-
Response to Imatinib Rechallenge of GIST That Recurs Following Completion of Adjuvant Imatinib Treatment - the First Analysis in the SSGXVIII/AIO Trial Patient PopulationReichardt, P. / Hartmann, J. T. / Hall, K. S. / Eriksson, M. / Schutte, J. / Ramadori, G. / Hohenberger, P. / Duyster, J. / Leinonen, M. / Joensuu, H. et al. | 2011
- 16
-
AVAPERL (MO22089): Final Efficacy Outcomes for Patients (pts) With Advanced Non-squamous Non-small Cell Lung Cancer (nsNSCLC) Randomised to Continuation Maintenance (mtc) with Bevacizumab (bev) or Bev + Pemetrexed (pern) After First-line (1L) Bev-cisplatin (cis)-pem Treatment (Tx)Barlesi, F. / de Castro, J. / Dvornichenko, V. / Kim, J. H. / Pazzola, A. / Rittmeyer, A. / Vikstrom, A. / Mitchell, L. / Wong, E. K. / Gorbunova, V. et al. | 2011
- 16
-
Evaluation of Individual Codon 12 and 13 Mutant (MT) KRAS Alleles as Prognostic and Predictive Biomarkers of Response to Panitumumab (pmab) in Patients with Metastatic Colorectal Cancer (mCRC)Peeters, M. / Douillard, J. Y. / Van Cutsem, E. / Siena, S. / Zhang, K. / Williams, R. / Wiezorek, J. et al. | 2011
- 33
-
Molecular mechanisms of leptin and adiponectin in breast cancerJarde, T. / Perrier, S. / Vasson, M. P. / Caldefie-Chezet, F. et al. | 2011
- 44
-
p53 and autophagy in cancer: Guardian of the genome meets guardian of the proteomeRyan, K. M. et al. | 2011
- 51
-
The prevalence and burden of symptoms amongst cancer patients attending palliative care in two African countriesHarding, R. / Selman, L. / Agupio, G. / Dinat, N. / Downing, J. / Gwyther, L. / Mashao, T. / Mmoledi, K. / Sebuyira, L. M. / Ikin, B. et al. | 2011
- 57
-
Quality of pathology reports for advanced ovarian cancer: Are we missing essential information?:An audit of 479 pathology reports from the EORTC-GCG 55971/NCIC-CTG OV13 neoadjuvant trialVerleye, L. / Ottevanger, P. B. / Kristensen, G. B. / Ehlen, T. / Johnson, N. / van der Burg, M. E. / Reed, N. S. / Verheijen, R. H. / Gaarenstroom, K. N. / Mosgaard, B. et al. | 2011
- 65
-
The acute skin and heart toxicity of a concurrent association of trastuzumab and locoregional breast radiotherapy including internal mammary chain: A single-institution studyCaussa, L. / Kirova, Y. M. / Gault, N. / Pierga, J. Y. / Savignoni, A. / Campana, F. / Dendale, R. / Fourquet, A. / Bollet, M. A. et al. | 2011
- 74
-
Safety of pregnancy following breast cancer diagnosis: A meta-analysis of 14 studiesAzim, H. A. / Santoro, L. / Pavlidis, N. / Gelber, S. / Kroman, N. / Azim, H. / Peccatori, F. A. et al. | 2011
- 84
-
High-dose cyclophosphamide-irinotecan-vincristine for primary refractory neuroblastomaKushner, B. H. / Kramer, K. / Modak, S. / Yataghene, K. / Cheung, N. K. et al. | 2011
- 90
-
Outcome of children and adolescents with relapsed acute lymphoblastic leukaemia and non-response to salvage protocol therapy: A retrospective analysis of the ALL-REZ BFM Study Groupvon Stackelberg, A. / Volzke, E. / Kuhl, J. S. / Seeger, K. / Schrauder, A. / Escherich, G. / Henze, G. / Tallen, G. et al. | 2011
- 98
-
Clustering of concordant and discordant cancer types in Swedish couples is rareWeires, M. / Bermejo, J. L. / Sundquist, J. / Hemminki, K. et al. | 2011
- 107
-
Promoter polymorphisms in matrix metallopeptidase 1 and risk of cutaneous melanomaWang, L. E. / Huang, Y. j. / Yin, M. / Gershenwald, J. E. / Prieto, V. G. / Lee, J. E. / Duvic, M. / Grimm, E. A. / Wei, Q. et al. | 2011
- 116
-
Association between Epstein-Barr virus infection and risk for development of pregnancy-associated breast cancer: Joint effect with vitamin D?Agborsangaya, C. B. / Lehtinen, T. / Toriola, A. T. / Pukkala, E. / Surcel, H. M. / Tedeschi, R. / Lehtinen, M. et al. | 2011
- 121
-
Four and a half LIM protein 2 (FHL2) negatively regulates the transcription of E-cadherin through interaction with Snail1Zhang, W. / Wang, J. / Zou, B. / Sardet, C. / Li, J. / Lam, C. S. / Ng, L. / Pang, R. / Hung, I. F. / Tan, V. P. et al. | 2011
- 131
-
Diagnostic and prognostic role of plasma levels of two forms of cytokeratin 18 in patients with non-small-cell lung cancerDe Petris, L. / Branden, E. / Herrmann, R. / Sanchez, B. C. / Koyi, H. / Linderholm, B. / Lewensohn, R. / Linder, S. / Lehtio, J. et al. | 2011
- 138
-
Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancerDedes, K. J. / Natrajan, R. / Lambros, M. B. / Geyer, F. C. / Lopez-Garcia, M. A. / Savage, K. / Jones, R. L. / Reis-Filho, J. S. et al. | 2011
- 151
-
MexTAg mice exposed to asbestos develop cancer that faithfully replicates key features of the pathogenesis of human mesotheliomaRobinson, C. / Walsh, A. / Larma, I. / O'Halloran, S. / Nowak, A. K. / Lake, R. A. et al. | 2011
- 163
-
MicroRNA regulation of core apoptosis pathways in cancerLima, R. T. / Busacca, S. / Almeida, G. M. / Gaudino, G. / Fennell, D. A. / Vasconcelos, M. H. et al. | 2011
- 175
-
Prognostic factors in women treated for ovarian yolk sac tumour: A retrospective analysis of 84 casesde La Motte Rouge, T. / Pautier, P. / Rey, A. / Duvillard, P. / Kerbrat, P. / Troalen, F. / Morice, P. / Haie-Meder, C. / Culine, S. / Lhomme, C. et al. | 2011
- 183
-
Psychometric validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24)Greimel, E. / Nordin, A. / Lanceley, A. / Creutzberg, C. L. / van de Poll-Franse, L. V. / Radisic, V. B. / Galalae, R. / Schmalz, C. / Barlow, E. / Jensen, P. T. et al. | 2011
- 191
-
Comparison of diaphragmatic surgery at primary or interval debulking in advanced ovarian carcinoma: An analysis of 163 patientsTsolakidis, D. / Amant, F. / Leunen, K. / Cadron, I. / Neven, P. / Vergote, I. et al. | 2011
- 199
-
A phase I, dose-escalation study of pomalidomide (CC-4047) in combination with gemcitabine in metastatic pancreas cancerInfante, J. R. / Jones, S. F. / Bendell, J. C. / Spigel, D. R. / Yardley, D. A. / Weekes, C. D. / Messersmith, W. A. / Hainsworth, J. D. / Burris, H. A. et al. | 2011
- 206
-
Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancerFischer von Weikersthal, L. / Schalhorn, A. / Stauch, M. / Quietzsch, D. / Maubach, P. A. / Lambertz, H. / Oruzio, D. / Schlag, R. / Weigang-Kohler, K. / Vehling-Kaiser, U. et al. | 2011
- 215
-
Are patients in clinical trials representative of the general population? Dose intensity and toxicities associated with FE100C-D chemotherapy in a non-trial population of node positive breast cancer patients compared with PACS-01 trial groupFraser, J. / Steele, N. / Al Zaman, A. / Yule, A. et al. | 2011
- 221
-
Follow-up care amongst long-term childhood cancer survivors: A report from the Swiss Childhood Cancer Survivor StudyRebholz, C. E. / von der Weid, N. X. / Michel, G. / Niggli, F. K. / Kuehni, C. E. et al. | 2011
- 230
-
Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium StudyGeoerger, B. / Chisholm, J. / Le Deley, M. C. / Gentet, J. C. / Zwaan, C. M. / Dias, N. / Jaspan, T. / Mc Hugh, K. / Couanet, D. / Hain, S. et al. | 2011
- 239
-
Prognostic significance of the initial cerebro-spinal fluid (CSF) involvement of children with acute lymphoblastic leukaemia (ALL) treated without cranial irradiation: Results of European Organization for Research and Treatment of Cancer (EORTC) Children Leukemia Group study 58881Sirvent, N. / Suciu, S. / Rialland, X. / Millot, F. / Benoit, Y. / Plantaz, D. / Ferster, A. / Robert, A. / Lutz, P. / Nelken, B. et al. | 2011
- 248
-
The relationship between new-onset diabetes mellitus and pancreatic cancer risk: A case-control studyBen, Q. / Cai, Q. / Li, Z. / Yuan, Y. / Ning, X. / Deng, S. / Wang, K. et al. | 2011
- 255
-
False-positive Human Papillomavirus DNA tests in cervical screening: It is all in a definitionRebolj, M. / Pribac, I. / Lynge, E. et al. | 2011
- 262
-
Relationship between changes in haemoglobin A1C and prostate-specific antigen in healthy menOhwaki, K. / Endo, F. / Muraishi, O. / Yano, E. et al. | 2011
- 267
-
Lifestyle factors associated concurrently and prospectively with co-morbid cardiovascular disease in a population-based cohort of colorectal cancer survivorsHawkes, A. L. / Lynch, B. M. / Owen, N. / Aitken, J. F. et al. | 2011
- 277
-
Sorafenib tosylate and paclitaxel induce anti-angiogenic, anti-tumour and anti-resorptive effects in experimental breast cancer bone metastasesMerz, M. / Komljenovic, D. / Zwick, S. / Semmler, W. / Bauerle, T. et al. | 2011
- 287
-
Prognostic determinants in epithelioid sarcomaGasparini, P. / Facchinetti, F. / Boeri, M. / Lorenzetto, E. / Livio, A. / Gronchi, A. / Ferrari, A. / Massimino, M. / Spreafico, F. / Giangaspero, F. et al. | 2011
- 296
-
Altered CD94/NKG2A and perforin expression reduce the cytotoxic activity in malignant pleural effusionsPace, E. / Di Sano, C. / Ferraro, M. / Tipa, A. / Olivieri, D. / Spatafora, M. / Santagata, R. / Bellia, V. / Gjomarkaj, M. et al. | 2011
- 305
-
Organ specific regulation of tumour invasiveness and gelatinolytic activity at the invasive frontHadler-Olsen, E. / Wetting, H. L. / Ravuri, C. / Omair, A. / Rikardsen, O. / Svineng, G. / Kanapathippillai, P. / Winberg, J. O. / Uhlin-Hansen, L. et al. | 2011
- 316
-
Grifolin, a potent antitumour natural product upregulates death-associated protein kinase 1 DAPK1 via p53 in nasopharyngeal carcinoma cellsLuo, X. j. / Li, L. l. / Deng, Q. p. / Yu, X. f. / Yang, L. f. / Luo, F. j. / Xiao, L. b. / Chen, X. y. / Ye, M. / Liu, J. k. et al. | 2011
- 326
-
Induction of senescence markers after neo-adjuvant chemotherapy of malignant pleural mesothelioma and association with clinical outcome: An exploratory analysisSidi, R. / Pasello, G. / Opitz, I. / Soltermann, A. / Tutic, M. / Rehrauer, H. / Weder, W. / Stahel, R. A. / Felley-Bosco, E. et al. | 2011
- 333
-
Glypican-3: A new target for cancer immunotherapyHo, M. / Kim, H. et al. | 2011
- 339
-
Serum CCL2 and serum TNF-a - Two new biomarkers predict bone invasion, post-treatment distant metastasis and poor overall survival in nasopharyngeal carcinomaLu, X. / Qian, C. N. / Mu, Y. G. / Li, N. W. / Li, S. / Zhang, H. B. / Li, S. W. / Wang, F. L. / Guo, X. / Xiang, Y. Q. et al. | 2011
- 347
-
Socioeconomic inequalities in the use of radiotherapy for rectal cancer: A nationwide studyOlsson, L. I. / Granstrom, F. / Glimelius, B. et al. | 2011
- 354
-
Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trialBurmeister, B. H. / Thomas, J. M. / Burmeister, E. A. / Walpole, E. T. / Harvey, J. A. / Thomson, D. B. / Barbour, A. P. / Gotley, D. C. / Smithers, B. M. et al. | 2011
- 361
-
Prognostic value of serial blood S100B determinations in stage IIB-III melanoma patients: A corollary study to EORTC trial 18952Bouwhuis, M. G. / Suciu, S. / Kruit, W. / Sales, F. / Stoitchkov, K. / Patel, P. / Cocquyt, V. / Thomas, J. / Lienard, D. / Eggermont, A. M. et al. | 2011
- 369
-
The effect of prophylactic calcium and magnesium infusions on the incidence of neurotoxicity and clinical outcome of oxaliplatin-based systemic treatment in advanced colorectal cancer patientsKnijn, N. / Tol, J. / Koopman, M. / Werter, M. J. / Imholz, A. L. / Valster, F. A. / Mol, L. / Vincent, A. D. / Teerenstra, S. / Punt, C. J. et al. | 2011
- 375
-
Reproducibility and validation of tumour stroma ratio scoring on oesophageal adenocarcinoma biopsiesCourrech Staal, E. F. / Smit, V. T. / van Velthuysen, M. L. / Spitzer-Naaykens, J. M. / Wouters, M. W. / Mesker, W. E. / Tollenaar, R. A. / van Sandick, J. W. et al. | 2011
- 383
-
Reliability and construct validity of the oral mucositis daily questionnaire in children with cancerTomlinson, D. / Ethier, M. C. / Judd, P. / Doyle, J. / Gassas, A. / Naqvi, A. / Sung, L. et al. | 2011
- 389
-
Pilot study of F18-Fluorodeoxyglucose Positron Emission Tomography/computerised tomography in Wilms' tumour: Correlation with conventional imaging, pathology and immunohistochemistryBegent, J. / Sebire, N. J. / Levitt, G. / Brock, P. / Jones, K. P. / Ell, P. / Gordon, I. / Anderson, J. et al. | 2011
- 397
-
Sexual function and experience among long-term survivors of childhood cancerSundberg, K. K. / Lampic, C. / Arvidson, J. / Helstrom, L. / Wettergren, L. et al. | 2011
- 404
-
C-reactive protein-associated genetic variants and cancer risk: Findings from FINRISK 1992, FINRISK 1997 and Health 2000 studiesHeikkila, K. / Silander, K. / Salomaa, V. / Jousilahti, P. / Koskinen, S. / Pukkala, E. / Perola, M. et al. | 2011
- 413
-
Polymorphic variation in the androgen receptor gene: Association with risk of testicular germ cell cancer and metastatic diseaseVastermark, a. / Giwercman, Y. L. / Hagstromer, O. / De-Meyts, E. R. / Eberhard, J. / Stahl, O. / Cedermark, G. C. / Rastkhani, H. / Daugaard, G. / Arver, S. et al. | 2011
- 420
-
Genetic variability of the fatty acid synthase pathway is not associated with prostate cancer risk in the European Prospective Investigation on Cancer (EPIC)Campa, D. / Husing, A. / Chang-Claude, J. / Dostal, L. / Boeing, H. / Kroger, J. / Tjonneland, A. / Roswall, N. / Overvad, K. / Dahm, C. C. et al. | 2011
- 428
-
Would the effect of HPV vaccination on non-cervical HPV-positive cancers make the difference for its cost-effectiveness?de Kok, I. M. / Habbema, J. D. / van Rosmalen, J. / van Ballegooijen, M. et al. | 2011
- 436
-
Consumption of animal products, olive oil and dietary fat and results from the Belgian case-control study on bladder cancer riskBrinkman, M. T. / Buntinx, F. / Kellen, E. / Van Dongen, M. C. / Dagnelie, P. C. / Muls, E. / Zeegers, M. P. et al. | 2011
- 443
-
Oncogenic mutations in gastric cancer with microsatellite instabilityCorso, G. / Velho, S. / Paredes, J. / Pedrazzani, C. / Martins, D. / Milanezi, F. / Pascale, V. / Vindigni, C. / Pinheiro, H. / Leite, M. et al. | 2011
- 452
-
Blockade of CXCR4 in oral squamous cell carcinoma inhibits lymph node metastasesUchida, D. / Onoue, T. / Kuribayashi, N. / Tomizuka, Y. / Tamatani, T. / Nagai, H. / Miyamoto, Y. et al. | 2011
- 460
-
Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rateSvobodova, S. / Browning, J. / MacGregor, D. / Pollara, G. / Scolyer, R. A. / Murali, R. / Thompson, J. F. / Deb, S. / Azad, A. / Davis, I. D. et al. | 2011
- 470
-
Expression of a truncated Hmga1b gene induces gigantism, lipomatosis and B-cell lymphomas in miceFedele, M. / Visone, R. / De Martino, I. / Palmieri, D. / Valentino, T. / Esposito, F. / Klein-Szanto, A. / Arra, C. / Ciarmiello, A. / Croce, C. M. et al. | 2011
- 479
-
A model of vascular tumour growth in mice combining longitudinal tumour size data with histological biomarkersRibba, B. / Watkin, E. / Tod, M. / Girard, P. / Grenier, E. / You, B. / Giraudo, E. / Freyer, G. et al. | 2011
- 491
-
Investment of palliative medicine in bridging the gap with academia: A call to actionMoroni, M. / Bolognesi, D. / Muciarelli, P. A. / Abernethy, A. P. / Biasco, G. et al. | 2011
- 496
-
Frontiers in targeting glioma stem cellsFrosina, G. et al. | 2011
- 508
-
Herbal therapy use by cancer patients: A literature review on case reportsOlaku, O. / White, J. D. et al. | 2011
- 515
-
Feasibility of metronomic oral cyclophosphamide plus prednisolone in elderly patients with inoperable or metastatic soft tissue sarcomaMir, O. / Domont, J. / Cioffi, A. / Bonvalot, S. / Boulet, B. / Le Pechoux, C. / Terrier, P. / Spielmann, M. / Le Cesne, A. et al. | 2011
- 520
-
MAPK and PI3K signalling differentially regulate angiogenic and lymphangiogenic cytokine secretion in squamous cell carcinoma of the head and neckLuangdilok, S. / Box, C. / Harrington, K. / Rhys-Evans, P. / Eccles, S. et al. | 2011
- 530
-
Six-month postoperative quality of life predicts long-term survival after oesophageal cancer surgeryDjarv, T. / Lagergren, P. et al. | 2011
- 536
-
An analysis of research activity in major UK cancer centresSullivan, R. / Lewison, G. / Purushotham, A. D. et al. | 2011
- 545
-
The excess burden of side-effects from treatment in men allocated to screening for prostate cancer. The Goteborg randomised population-based prostate cancer screening trialCarlsson, S. / Aus, G. / Bergdahl, S. / Khatami, A. / Lodding, P. / Stranne, J. / Hugosson, J. et al. | 2011
- 554
-
Validation of the QUAL-EC for assessing quality of life in patients with advanced cancerLo, C. / Burman, D. / Swami, N. / Gagliese, L. / Rodin, G. / Zimmermann, C. et al. | 2011
- 561
-
Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: A report from the International Neuroblastoma Risk Group ProjectMoroz, V. / Machin, D. / Faldum, A. / Hero, B. / Iehara, T. / Mosseri, V. / Ladenstein, R. / Bernardi, B. D. / Rubie, H. / Berthold, F. et al. | 2011
- 572
-
Short topotecan-based induction regimen in newly diagnosed high-risk neuroblastomaDe Ioris, M. A. / Castellano, A. / Ilari, I. / Garganese, M. C. / Natali, G. / Inserra, A. / Vito, R. D. / Rava, L. / Pasquale, M. D. / Locatelli, F. et al. | 2011
- 579
-
Epidemiology and survival of Merkel cell carcinoma in the Netherlands. A population-based study of 808 cases in 1993-2007Reichgelt, B. A. / Visser, O. et al. | 2011
- 586
-
Does the time interval between first and last birth influence the risk of endometrial and ovarian cancer?Bevier, M. / Sundquist, J. / Hemminki, K. et al. | 2011
- 592
-
Parity, early menopause and the incidence of bladder cancer in women: A case-control study and meta-analysisDietrich, K. / Demidenko, E. / Schned, A. / Zens, M. S. / Heaney, J. / Karagas, M. R. et al. | 2011
- 600
-
S100A14 regulates the invasive potential of oral squamous cell carcinoma derived cell-lines in vitro by modulating expression of matrix metalloproteinases, MMP1 and MMP9Sapkota, D. / Bruland, O. / Costea, D. E. / Haugen, H. / Vasstrand, E. N. / Ibrahim, S. O. et al. | 2011
- 611
-
Mucosal immune environment in colonic carcinogenesis: CD80 up-regulation in colonic dysplasia in ulcerative colitisScarpa, M. / Bortolami, M. / Cecchetto, A. / Faggian, D. / Kotsafti, A. / Ruffolo, C. / Navaglia, F. / Pozza, A. / D'Inca, R. / Plebani, M. et al. | 2011
- 620
-
Impact of smoking on the expression of claudins in lung carcinomaMerikallio, H. / Kaarteenaho, R. / Paakko, P. / Lehtonen, S. / Hirvikoski, P. / Makitaro, R. / Harju, T. / Soini, Y. et al. | 2011
- 631
-
E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancerCorso, G. / Pedrazzani, C. / Pinheiro, H. / Fernandes, E. / Marrelli, D. / Rinnovati, A. / Pascale, V. / Seruca, R. / Oliveira, C. / Roviello, F. et al. | 2011
- 640
-
The acridone derivative MBLI-87 sensitizes breast cancer resistance protein-expressing xenografts to irinotecanArnaud, O. / Boumendjel, A. / Geze, A. / Honorat, M. / Matera, E. L. / Guitton, J. / Stein, W. D. / Bates, S. E. / Falson, P. / Dumontet, C. et al. | 2011
- 649
-
Management of cerebral metastasis: Evidence-based approach for surgery, stereotactic radiosurgery and radiotherapyJenkinson, M. D. / Haylock, B. / Shenoy, A. / Husband, D. / Javadpour, M. et al. | 2011
- 656
-
Factors contributing to the efficacy of concurrent-adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Combined analyses of NPC-9901 and NPC-9902 TrialsLee, A. W. / Tung, S. Y. / Ngan, R. K. / Chappell, R. / Chua, D. T. / Lu, T. X. / Siu, L. / Tan, T. / Chan, L. K. / Ng, W. T. et al. | 2011
- 667
-
Normative data for the EORTC QLQ-C30 and EORTC-sexuality items in the general Dutch populationvan de Poll-Franse, L. V. / Mols, F. / Gundy, C. M. / Creutzberg, C. L. / Nout, R. A. / Verdonck-de Leeuw, I. M. / Taphoorn, M. J. / Aaronson, N. K. et al. | 2011
- 676
-
The value of routine physical examination in the follow up of women with a history of early breast cancerLu, W. / de Bock, G. H. / Schaapveld, M. / Baas, P. C. / Wiggers, T. / Jansen, L. et al. | 2011
- 683
-
Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: Final results from CALGB trial 79809Shapiro, C. L. / Halabi, S. / Hars, V. / Archer, L. / Weckstein, D. / Kirshner, J. / Sikov, W. / Winer, E. / Burstein, H. J. / Hudis, C. et al. | 2011
- 690
-
Immunomodulatory effects of sorafenib on peripheral immune effector cells in metastatic renal cell carcinomaBusse, A. / Asemissen, A. M. / Nonnenmacher, A. / Braun, F. / Ochsenreither, S. / Stather, D. / Fusi, A. / Schmittel, A. / Miller, K. / Thiel, E. et al. | 2011
- 697
-
Recommendations for capture, validation and summarisation of data from studies using RECISTPaules, M. / Casey, M. / Williams, G. / Swann, R. S. / Murphy, P. S. / Salazar, V. M. / Foose, D. / Bailey, B. / Therasse, P. et al. | 2011
- 702
-
The development of evidence-based European guidelines on the management of depression in palliative cancer careRayner, L. / Price, A. / Hotopf, M. / Higginson, I. J. et al. | 2011
- 713
-
Does pain intensity predict a poor opioid response in cancer patients?Mercadante, S. / Gebbia, V. / David, F. / Aielli, F. / Verna, L. / Porzio, G. / Ferrera, P. / Casuccio, A. / Ficorella, C. et al. | 2011
- 718
-
Microscopic neoplastic thrombosis in localised nephroblastoma: Does it influence outcome?De Ioris, M. A. / Aloi, I. / Camassei, F. D. / Rava, L. / Boldrini, R. / De Sio, L. / De Laurentis, C. / Castellano, A. / Crocoli, A. / Locatelli, F. et al. | 2011
- 724
-
Non-metastatic unresected paediatric non-rhabdomyosarcoma soft tissue sarcomas: Results of a pooled analysis from United States and European groupsFerrari, A. / Miceli, R. / Rey, A. / Oberlin, O. / Orbach, D. / Brennan, B. / Mariani, L. / Carli, M. / Bisogno, G. / Cecchetto, G. et al. | 2011
- 732
-
Relationship between sun exposure and melanoma risk for tumours in different body sites in a large case-control study in a temperate climateNewton-Bishop, J. A. / Chang, Y. M. / Elliott, F. / Chan, M. / Leake, S. / Karpavicius, B. / Haynes, S. / Fitzgibbon, E. / Kukalizch, K. / Randerson-Moor, J. et al. | 2011
- 742
-
Chlamydia pneumoniae infection and lung cancer risk: A meta-analysisZhan, P. / Suo, L. j. / Qian, Q. / Shen, X. k. / Qiu, L. X. / Yu, L. k. / Song, Y. et al. | 2011
- 748
-
Physical activity and lymphoid neoplasms in the European Prospective Investigation into Cancer and nutrition (EPIC)van Veldhoven, C. M. / Khan, A. E. / Teucher, B. / Rohrmann, S. / Raaschou-Nielsen, O. / Tjonneland, A. / Overvad, K. / Vigl, M. / Boeing, H. / Benetou, V. et al. | 2011
- 761
-
Caveolin 1 is a marker of poor differentiation in RhabdomyosarcomaRossi, S. / Poliani, P. L. / Cominelli, M. / Bozzato, A. / Vescovi, R. / Monti, E. / Fanzani, A. et al. | 2011
- 773
-
A novel hybrid peptide targeting EGFR-expressing cancersKohno, M. / Horibe, T. / Haramoto, M. / Yano, Y. / Ohara, K. / Nakajima, O. / Matsuzaki, K. / Kawakami, K. et al. | 2011
- 784
-
A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosisLiu, R. / Zhang, C. / Hu, Z. / Li, G. / Wang, C. / Yang, C. / Huang, D. / Chen, X. / Zhang, H. / Zhuang, R. et al. | 2011
- 792
-
Protein kinase CK2a subunit over-expression correlates with metastatic risk in breast carcinomas: Quantitative immunohistochemistry in tissue microarraysGiusiano, S. / Cochet, C. / Filhol, O. / Duchemin-Pelletier, E. / Secq, V. / Bonnier, P. / Carcopino, X. / Boubli, L. / Birnbaum, D. / Garcia, S. et al. | 2011
- 802
-
Diagnostic and prognostic value of alpha internexin expression in a series of 409 gliomasDucray, F. / Mokhtari, K. / Criniere, E. / Idbaih, A. / Marie, Y. / Dehais, C. / Paris, S. / Carpentier, C. / Dieme, M. J. / Adam, C. et al. | 2011
- 811
-
Time for paediatric febrile neutropenia guidelines - children are not little adultsSung, L. / Phillips, R. / Lehrnbecher, T. et al. | 2011
- 814
-
Previous thalidomide therapy may not affect lenalidomide response and outcome in relapse or refractory multiple myeloma patientsGuglielmelli, T. / Bringhen, S. / Rrodhe, S. / Gay, F. / Cavallo, F. / Berruti, A. / Montefusco, V. / Piro, E. / Benevolo, G. / Petrucci, M. T. et al. | 2011
- 819
-
Statins and prostate cancer: Molecular and clinical aspectsPapadopoulos, G. / Delakas, D. / Nakopoulou, L. / Kassimatis, T. et al. | 2011
- 831
-
Effect of omeprazole on the pharmacokinetics and toxicities of irinotecan in cancer patients: A prospective cross-over drug-drug interaction studyvan der Bol, J. M. / Loos, W. J. / de Jong, F. A. / van Meerten, E. / Konings, I. R. / Lam, M. H. / de Bruijn, P. / Wiemer, E. A. / Verweij, J. / Mathijssen, R. H. et al. | 2011
- 839
-
Association of RRM1 -37A>C polymorphism with clinical outcome in colorectal cancer patients treated with gemcitabine-based chemotherapyRodriguez, J. / Boni, V. / Hernandez, A. / Bitarte, N. / Zarate, R. / Ponz-Sarvise, M. / Chopitea, A. / Bandres, E. / Garcia-Foncillas, J. et al. | 2011
- 848
-
Changes of bone resorption marker (NTX) in chemotherapy plus zoledronic acid versus chemotherapy alone for nasopharyngeal cancer patients with bone metastasesZhao, Y. Y. / Xue, C. / Hou, X. / Liao, H. / Li, S. / Zhao, H. Y. / Huang, Y. / Chen, L. K. / Xu, F. / Liu, J. L. et al. | 2011
- 854
-
Randomised controlled trials in oncology closed early for benefit: Trends in methodology, results, and interpretationBooth, C. M. / Ohorodnyk, P. / Zhu, L. / Tu, D. / Meyer, R. M. et al. | 2011
- 864
-
A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: Extended follow up in the ARTISTIC trialKitchener, H. C. / Gilham, C. / Sargent, A. / Bailey, A. / Albrow, R. / Roberts, C. / Desai, M. / Mather, J. / Turner, A. / Moss, S. et al. | 2011
- 872
-
Stage migration after introduction of sentinel lymph node dissection in breast cancer treatment in Denmark: A nationwide studyTvedskov, T. F. / Jensen, M. B. / Balslev, E. / Ejlertsen, B. / Kroman, N. et al. | 2011
- 879
-
Preoperative MRI and surgical management in patients with nonpalpable breast cancer: The MONET - Randomised controlled trialPeters, N. H. / van Esser, S. / van den Bosch, M. A. / Storm, R. K. / Plaisier, P. W. / van Dalen, T. / Diepstraten, S. C. / Weits, T. / Westenend, P. J. / Stapper, G. et al. | 2011
- 887
-
Distinction of isolated tumour cells and micrometastasis in lymph nodes of breast cancer patients according to the new Tumour Node Metastasis (TNM) definitionsCserni, G. / Amendoeira, I. / Bianchi, S. / Chmielik, E. / DeGaetano, J. / Faverly, D. / Figueiredo, P. / Foschini, M. P. / Grabau, D. / Jacquemier, J. et al. | 2011
- 895
-
Survival after recurrent osteosarcoma: Data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trialsGelderblom, H. / Jinks, R. C. / Sydes, M. / Bramwell, V. H. / van Glabbeke, M. / Grimer, R. J. / Hogendoorn, P. C. / McTiernan, A. / Lewis, I. J. / Nooij, M. A. et al. | 2011
- 903
-
Prediction of prostate cancer in unscreened men: External validation of a risk calculatorvan Vugt, H. A. / Roobol, M. J. / Kranse, R. / Maattanen, L. / Finne, P. / Hugosson, J. / Bangma, C. H. / Schroder, F. H. / Steyerberg, E. W. et al. | 2011
- 910
-
Socioeconomic inequalities in prognostic markers of non-Hodgkin lymphoma: Analysis of a national clinical databaseFrederiksen, B. L. / Brown, P. d. / Dalton, S. O. / Steding-Jessen, M. / Osler, M. et al. | 2011
- 918
-
High claudin-7 expression is associated with a poor response to platinum-based chemotherapy in epithelial ovarian carcinomaKim, C. J. / Lee, J. W. / Choi, J. J. / Choi, H. Y. / Park, Y. A. / Jeon, H. K. / Sung, C. O. / Song, S. Y. / Lee, Y. Y. / Choi, C. H. et al. | 2011
- 926
-
TAZ/WWTR1 is overexpressed in papillary thyroid carcinomade Cristofaro, T. / Di Palma, T. / Ferraro, A. / Corrado, A. / Lucci, V. / Franco, R. / Fusco, A. / Zannini, M. et al. | 2011
- 934
-
Inhibitor of DNA binding-1 induces mesenchymal features and promotes invasiveness in thyroid tumour cellsCiarrocchi, A. / Piana, S. / Valcavi, R. / Gardini, G. / Casali, B. et al. | 2011
- 946
-
Risk for second primary non-breast cancer in pre- and postmenopausal women with breast cancer not treated with chemotherapy, radiotherapy or endocrine therapyLangballe, R. / Olsen, J. H. / Andersson, M. / Mellemkjaer, L. et al. | 2011
- 953
-
miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasionFowler, A. / Thomson, D. / Giles, K. / Maleki, S. / Mreich, E. / Wheeler, H. / Leedman, P. / Biggs, M. / Cook, R. / Little, N. et al. | 2011
- 965
-
Paediatric intestinal cancer and polyposis due to bi-allelic PMS2 mutations: Case series, review and follow-up guidelinesHerkert, J. C. / Niessen, R. C. / Olderode-Berends, M. J. / Veenstra-Knol, H. E. / Vos, Y. J. / van der Klift, H. M. / Scheenstra, R. / Tops, C. M. / Karrenbeld, A. / Peters, F. T. et al. | 2011
- 983
-
Reducing sample sizes in two-stage phase II cancer trials by using continuous tumour shrinkage end-pointsWason, J. M. / Mander, A. P. / Eisen, T. G. et al. | 2011
- 990
-
Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: Data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, C-06, C-07 and C89803Sargent, D. / Shi, Q. / Yothers, G. / Van Cutsem, E. / Cassidy, J. / Saltz, L. / Wolmark, N. / Bot, B. / Grothey, A. / Buyse, M. et al. | 2011
- 997
-
Phase I trial of vandetanib and bevacizumab evaluating the VEGF and EGF signal transduction pathways in adults with solid tumours and lymphomasKummar, S. / Gutierrez, M. E. / Chen, A. / Turkbey, I. B. / Allen, D. / Horneffer, Y. R. / Juwara, L. / Cao, L. / Yu, Y. / Kim, Y. S. et al. | 2011
- 1006
-
Predictive impact of DNA repair functionality on clinical outcome of advanced sarcoma patients treated with trabectedin: A retrospective multicentric studySchoffski, P. / Taron, M. / Jimeno, J. / Grosso, F. / Sanfilipio, R. / Casali, P. G. / Cesne, A. L. / Jones, R. L. / Blay, J. Y. / Poveda, A. et al. | 2011
- 1013
-
Prognostic value of survivin expression in parotid gland cancer in consideration of different histological subtypesStenner, M. / Demgensky, A. / Molls, C. / Hardt, A. / Luers, J. C. / Grosheva, M. / Huebbers, C. U. / Klussmann, J. P. et al. | 2011
- 1021
-
Evidence of the effect of adjunct ultrasound screening in women with mammography-negative dense breasts: Interval breast cancers at 1year follow-upCorsetti, V. / Houssami, N. / Ghirardi, M. / Ferrari, A. / Speziani, M. / Bellarosa, S. / Remida, G. / Gasparotti, C. / Galligioni, E. / Ciatto, S. et al. | 2011
- 1027
-
Nurse-led telephone follow-up and an educational group programme after breast cancer treatment: Results of a 2x2 randomised controlled trialKimman, M. L. / Dirksen, C. D. / Voogd, A. C. / Falger, P. / Gijsen, B. C. / Thuring, M. / Lenssen, A. / van der Ent, F. / Verkeyn, J. / Haekens, C. et al. | 2011
- 1037
-
A multicentre dose-escalating study of cabazitaxel (XRP6258) in combination with capecitabine in patients with metastatic breast cancer progressing after anthracycline and taxane treatment: A phase I/II studyVillanueva, C. / Awada, A. / Campone, M. / Machiels, J. P. / Besse, T. / Magherini, E. / Dubin, F. / Semiond, D. / Pivot, X. et al. | 2011
- 1046
-
First evidence for digenic inheritance in hereditary colorectal cancer by mutations in the base excision repair genesMorak, M. / Massdorf, T. / Sykora, H. / Kerscher, M. / Holinski-Feder, E. et al. | 2011
- 1056
-
Sociodemographic factors and incidence of melanoma in the Netherlands, 1994-2005van der Aa, M. A. / de Vries, E. / Hoekstra, H. J. / Coebergh, J. W. / Siesling, S. et al. | 2011
- 1061
-
Increased cancer risks among arthroplasty patients: 30year follow-up of the Swedish Knee Arthroplasty RegisterWagner, P. / Olsson, H. / Lidgren, L. / Robertsson, O. / Ranstam, J. et al. | 2011
- 1072
-
Lack of association of IL-10 gene polymorphisms with prostate cancer: Evidence from 11,581 subjectsZou, Y. F. / Wang, F. / Feng, X. L. / Tian, Y. H. / Tao, J. H. / Pan, F. M. / Huang, F. et al. | 2011
- 1080
-
Brachyury expression predicts poor prognosis at early stages of colorectal cancerKilic, N. / Feldhaus, S. / Kilic, E. / Tennstedt, P. / Wicklein, D. / Wasielewski, R. v. / Viebahn, C. / Kreipe, H. / Schumacher, U. et al. | 2011
- 1086
-
Expression of DNA repair genes in ovarian cancer samples: Biological and clinical considerationsGanzinelli, M. / Mariani, P. / Cattaneo, D. / Fossati, R. / Fruscio, R. / Corso, S. / Ricci, F. / Broggini, M. / Damia, G. et al. | 2011
- 1095
-
Differentiation of human rhabdomyosarcoma RD cells is regulated by reciprocal, functional interactions between myostatin, p38 and extracellular regulated kinase signalling pathwaysRossi, S. / Stoppani, E. / Puri, P. L. / Fanzani, A. et al. | 2011
- 1106
-
Prognostic value of opioid binding protein/cell adhesion molecule-like promoter methylation in bladder carcinomaDuarte-Pereira, S. / Paiva, F. / Costa, V. L. / Ramalho-Carvalho, J. / Savva-Bordalo, J. / Rodrigues, A. / Ribeiro, F. R. / Silva, V. M. / Oliveira, J. / Henrique, R. et al. | 2011
- 1115
-
Des-g-carboxyl prothrombin induces matrix metalloproteinase activity in hepatocellular carcinoma cells by involving the ERK1/2 MAPK signalling pathwayYue, P. / Gao, Z. H. / Xue, X. / Cui, S. X. / Zhao, C. R. / Yuan, Y. / Yin, Z. / Inagaki, Y. / Kokudo, N. / Tang, W. et al. | 2011
- 1125
-
Assessing downgrading of locally advanced rectal cancer after chemo-radiotherapyZlobec, I. et al. | 2011
- 1127
-
The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosisBabashah, S. / Soleimani, M. et al. | 2011
- 1138
-
Prognostic importance of Mandard tumour regression grade following pre-operative chemo/radiotherapy for locally advanced rectal cancerDhadda, A. S. / Dickinson, P. / Zaitoun, A. M. / Gandhi, N. / Bessell, E. M. et al. | 2011
- 1146
-
Docetaxel and irinotecan as second-line therapy for advanced oesophagogastric cancerHawkes, E. / Okines, A. F. / Papamichael, D. / Rao, S. / Ashley, S. / Charalambous, H. / Koukouma, A. / Chau, I. / Cunningham, D. et al. | 2011
- 1152
-
A new, simple and objective prognostic score for phase I cancer patientsFussenich, L. M. / Desar, I. M. / Peters, M. E. / Teerenstra, S. / van der Graaf, W. T. / Timmer-Bonte, J. N. / van Herpen, C. M. et al. | 2011
- 1161
-
Haematologic toxicities associated with the addition of bevacizumab in cancer patientsSchutz, F. A. / Jardim, D. L. / Je, Y. / Choueiri, T. K. et al. | 2011
- 1175
-
Economic evaluation of four follow-up strategies after curative treatment for breast cancer: Results of an RCTKimman, M. L. / Dirksen, C. D. / Voogd, A. C. / Falger, P. / Gijsen, B. C. / Thuring, M. / Lenssen, A. / van der Ent, F. / Verkeyn, J. / Haekens, C. et al. | 2011
- 1186
-
Prognostic value of axillary lymph node status after neoadjuvant chemotherapy. Results from a multicentre studySaxena, N. / Hartman, M. / Aziz, R. / Rapiti, E. / Bhoo Pathy, N. / Lim, S. E. / Iau, P. / Taib, N. A. / Schaffar, R. / Neyroud-Caspar, I. et al. | 2011
- 1193
-
The prognostic value of fast molecular response of marrow disease in patients aged over 1year with stage 4 neuroblastomaStutterheim, J. / Zappeij-Kannegieter, L. / Versteeg, R. / Caron, H. N. / van der Schoot, C. E. / Tytgat, G. A. et al. | 2011
- 1203
-
TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancerCastro, F. A. / Forsti, A. / Buch, S. / Kalthoff, H. / Krauss, C. / Bauer, M. / Egberts, J. / Schniewind, B. / Broering, D. C. / Schreiber, S. et al. | 2011
- 1211
-
The prevalence of premalignant gastric lesions in asymptomatic patients: Predicting the future incidence of gastric cancerden Hoed, C. M. / van Eijck, B. C. / Capelle, L. G. / van Dekken, H. / Biermann, K. / Siersema, P. D. / Kuipers, E. J. et al. | 2011
- 1219
-
The glutathione transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) increases temozolomide efficacy against malignant melanomaTentori, L. / Dorio, A. S. / Mazzon, E. / Muzi, A. / Sau, A. / Cuzzocrea, S. / Vernole, P. / Federici, G. / Caccuri, A. M. / Graziani, G. et al. | 2011
- 1231
-
Primary resistance to cetuximab in a panel of patient-derived tumour xenograft models: Activation of MET as one mechanism for drug resistanceKrumbach, R. / Schuler, J. / Hofmann, M. / Giesemann, T. / Fiebig, H. H. / Beckers, T. et al. | 2011
- 1244
-
Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001Kuo, S. H. / Hsu, C. H. / Chen, L. T. / Lu, Y. S. / Lin, C. H. / Yeh, P. Y. / Jeng, H. J. / Gao, M. / Yeh, K. H. / Cheng, A. L. et al. | 2011
- 1258
-
Expression of insulin-like growth factor system components in Ewing's sarcoma and their association with survivalScotlandi, K. / Manara, M. C. / Serra, M. / Marino, M. T. / Ventura, S. / Garofalo, C. / Alberghini, M. / Magagnoli, G. / Ferrari, S. / Lopez-Guerrero, J. A. et al. | 2011
- 1267
-
Gene expression profiling of human angiotropic primary melanoma: Selection of 15 differentially expressed genes potentially involved in extravascular migratory metastasisLugassy, C. / Lazar, V. / Dessen, P. / van den Oord, J. J. / Winnepenninckx, V. / Spatz, A. / Bagot, M. / Bensussan, A. / Janin, A. / Eggermont, A. M. et al. | 2011
- 1276
-
Microvascular biodistribution of L19-SIP in angiogenesis targeting strategiesCzabanka, M. / Parmaksiz, G. / Bayerl, S. H. / Nieminen, M. / Trachsel, E. / Menssen, H. D. / Erber, R. / Neri, D. / Vajkoczy, P. et al. | 2011
- 1285
-
The pharmacoeconomics of spiralling cancer drug costs - Is there a viable solution?Alifrangis, C. / Krell, J. / Stebbing, J. et al. | 2011
- 1287
-
Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinomaPorta, C. / Osanto, S. / Ravaud, A. / Climent, M. A. / Vaishampayan, U. / White, D. A. / Creel, P. / Dickow, B. / Fischer, P. / Gornell, S. S. et al. | 2011
- 1299
-
The development of a value based pricing index for new drugs in metastatic colorectal cancerDranitsaris, G. / Truter, I. / Lubbe, M. S. et al. | 2011
- 1305
-
Mutational spectrum and therapy response of metastasized GIST in Central Switzerland - A population-based studyRossle, M. / Hirschmann, A. / Diebold, J. et al. | 2011
- 1312
-
Prognostic significance of interim 18F-FDG PET/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphomaYang, D. H. / Min, J. J. / Song, H. C. / Jeong, Y. Y. / Chung, W. K. / Bae, S. Y. / Ahn, J. S. / Kim, Y. K. / Bom, H. S. / Chung, I. J. et al. | 2011
- 1319
-
Topoisomerase II-alpha protein expression and histological response following doxorubicin-based induction chemotherapy predict survival of locally advanced soft tissues sarcomasRodrigo, R. S. / Nathalie, A. / Elodie, T. / Gonzalo, G. A. / Philippe, T. / Francoise, D. / Julien, D. / Angela, C. / Berenice, B. / Jean-Yves, B. et al. | 2011
- 1328
-
Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumoursde Jonge, M. J. / Dumez, H. / Kitzen, J. J. / Beuselinck, B. / Verweij, J. / Courtney, R. / Battista, A. / Brega, N. / Schoffski, P. et al. | 2011
- 1336
-
Phase II trial of the combination of carboplatin and irinotecan in elderly patients with small-cell lung cancerMurata, Y. / Hirose, T. / Yamaoka, T. / Shirai, T. / Okuda, K. / Sugiyama, T. / Kusumoto, S. / Nakashima, M. / Ohmori, T. / Adachi, M. et al. | 2011
- 1343
-
A systematic review and meta-analysis of KRAS status as the determinant of response to anti-EGFR antibodies and the impact of partner chemotherapy in metastatic colorectal cancerAdelstein, B. A. / Dobbins, T. A. / Harris, C. A. / Marschner, I. C. / Ward, R. L. et al. | 2011
- 1355
-
Weekly docetaxel in metastatic breast cancer patients: No superior benefits compared to three-weekly docetaxelSchroder, C. P. / de Munck, L. / Westermann, A. M. / Smit, W. M. / Creemers, G. J. / de Graaf, H. / Stouthard, J. M. / van Deijk, G. / Erjavec, Z. / van Bochove, A. et al. | 2011
- 1363
-
Psychosocial group intervention for patients with primary breast cancer: A randomised trialBoesen, E. H. / Karlsen, R. / Christensen, J. / Paaschburg, B. / Nielsen, D. / Bloch, I. S. / Christiansen, B. / Jacobsen, K. / Johansen, C. et al. | 2011
- 1373
-
The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: A report from the Dana-Farber Cancer Institute ALL ConsortiumVrooman, L. M. / Neuberg, D. S. / Stevenson, K. E. / Asselin, B. L. / Athale, U. H. / Clavell, L. / Cole, P. D. / Kelly, K. M. / Larsen, E. C. / Laverdiere, C. et al. | 2011
- 1380
-
Neurocognitive functioning and health-related behaviours in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor StudyKrull, K. R. / Annett, R. D. / Pan, Z. / Ness, K. K. / Nathan, P. C. / Srivastava, D. K. / Stovall, M. / Robison, L. L. / Hudson, M. M. et al. | 2011
- 1389
-
Treatment of recurrent central nervous system primitive neuroectodermal tumours in children and adolescents: Results of a Children's Cancer and Leukaemia Group studyPizer, B. / Donachie, P. H. / Robinson, K. / Taylor, R. E. / Michalski, A. / Punt, J. / Ellison, D. W. / Picton, S. et al. | 2011
- 1398
-
Differences according to educational level in the management and survival of colorectal cancer in SwedenCavalli-Bjorkman, N. / Lambe, M. / Eaker, S. / Sandin, F. / Glimelius, B. et al. | 2011
- 1407
-
Young age and a positive family history of colorectal cancer are complementary selection criteria for the identification of Lynch syndromeManders, P. / Spruijt, L. / Kets, C. M. / Willems, H. W. / Bodmer, D. / Hebeda, K. M. / Nagtegaal, I. D. / van Krieken, J. H. / Ligtenberg, M. J. / Hoogerbrugge, N. et al. | 2011
- 1414
-
Overexpression of Dicer predicts poor survival in colorectal cancerFaber, C. / Horst, D. / Hlubek, F. / Kirchner, T. et al. | 2011
- 1420
-
Phosphoprotein pathway profiling of ovarian carcinoma for the identification of potential new targets for therapyFaratian, D. / Um, I. / Wilson, D. S. / Mullen, P. / Langdon, S. P. / Harrison, D. J. et al. | 2011
- 1432
-
Anticancer effects of the p53 activator nutlin-3 in Ewing's sarcoma cellsSonnemann, J. / Palani, C. D. / Wittig, S. / Becker, S. / Eichhorn, F. / Voigt, A. / Beck, J. F. et al. | 2011
- 1443
-
Phase 1 trials of molecular targeted therapies: Are we evaluating toxicities properly?Soria, J. C. et al. | 2011
- 1446
-
Motor vehicle exposure and risk of oesophageal adenocarcinomaLagergren, J. / Jansson, C. / Lu, Y. et al. | 2011
- 1450
-
The preclinical and clinical activity of aviscumine: A potential anticancer drugZwierzina, H. / Bergmann, L. / Fiebig, H. / Aamdal, S. / Schoffski, P. / Witthohn, K. / Lentzen, H. et al. | 2011
- 1458
-
Critical review of economic evaluations in multiple myeloma: An overview of the economic evidence and quality of the methodologyGaultney, J. G. / Redekop, W. K. / Sonneveld, P. / Uyl-de Groot, C. A. et al. | 2011
- 1468
-
Heterogeneity in the definition of dose-limiting toxicity in phase I cancer clinical trials of molecularly targeted agents: A review of the literatureLe Tourneau, C. / Razak, A. R. / Gan, H. K. / Pop, S. / Dieras, V. / Tresca, P. / Paoletti, X. et al. | 2011
- 1476
-
Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: Final results of a randomised phase III study (EORTC 18032)Patel, P. M. / Suciu, S. / Mortier, L. / Kruit, W. H. / Robert, C. / Schadendorf, D. / Trefzer, U. / Punt, C. J. / Dummer, R. / Davidson, N. et al. | 2011
- 1484
-
A phase I study of sirolimus and bevacizumab in patients with advanced malignanciesCohen, E. E. / Sharma, M. R. / Janisch, L. / Llobrera, M. / House, L. / Wu, K. / Ramirez, J. / Fleming, G. F. / Stadler, W. M. / Ratain, M. J. et al. | 2011
- 1490
-
Reasons given by patients for participating, or not, in Phase 1 cancer trialsCatt, S. / Langridge, C. / Fallowfield, L. / Talbot, D. C. / Jenkins, V. et al. | 2011
- 1498
-
A randomised phase II trial of 1month versus 1year of adjuvant high-dose interferon a-2b in high-risk acral melanoma patientsMao, L. / Si, L. / Chi, Z. / Cui, C. / Sheng, X. / Li, S. / Tang, B. / Guo, J. et al. | 2011
- 1504
-
Adherence to national guidelines for treatment and outcome of endometrial cancer stage I in relation to co-morbidity in southern Netherlands 1995-2008Boll, D. / Verhoeven, R. H. / van der Aa, M. A. / Lybeert, M. L. / Coebergh, J. W. / Janssen-Heijnen, M. L. et al. | 2011
- 1511
-
An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancerMoehler, M. / Mueller, A. / Hartmann, J. T. / Ebert, M. P. / Al-Batran, S. E. / Reimer, P. / Weihrauch, M. / Lordick, F. / Trarbach, T. / Biesterfeld, S. et al. | 2011
- 1521
-
One-month relative dose intensity of not less than 50% predicts favourable progression-free survival in sorafenib therapy for advanced renal cell carcinoma in Japanese patientsKawashima, A. / Takayama, H. / Arai, Y. / Tanigawa, G. / Nin, M. / Kajikawa, J. / Imazu, T. / Kinoshita, T. / Yasunaga, Y. / Inoue, H. et al. | 2011
- 1527
-
Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44+CD24lo cancer stem cell phenotypeReuben, J. M. / Lee, B. N. / Gao, H. / Cohen, E. N. / Mego, M. / Giordano, A. / Wang, X. / Lodhi, A. / Krishnamurthy, S. / Hortobagyi, G. N. et al. | 2011
- 1537
-
Peritumoural vascular invasion: A major determinant of triple-negative breast cancer outcomeSabatier, R. / Jacquemier, J. / Bertucci, F. / Esterni, B. / Finetti, P. / Azario, F. / Birnbaum, D. / Viens, P. / Goncalves, A. / Extra, J. M. et al. | 2011
- 1546
-
Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study GroupKoch, A. / Bergman, B. / Holmberg, E. / Sederholm, C. / Ek, L. / Kosieradzki, J. / Lamberg, K. / Thaning, L. / Ydreborg, S. O. / Sorenson, S. et al. | 2011
- 1556
-
Pharmacokinetics of cyclophosphamide and its metabolites in paediatric patients receiving high-dose myeloablative therapyChinnaswamy, G. / Errington, J. / Foot, A. / Boddy, A. V. / Veal, G. J. / Cole, M. et al. | 2011
- 1564
-
Couples' communication before the wife's death to cancer and the widower's feelings of guilt or regret after the loss - A population-based investigationJonasson, J. M. / Hauksdottir, A. / Nemes, S. / Surkan, P. J. / Valdimarsdottir, U. / Onelov, E. / Steineck, G. et al. | 2011
- 1571
-
Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screeningDekker, N. / van Rossum, L. G. / Van Vugt-van Pinxteren, M. / van Stiphout, S. H. / Hermens, R. P. / van Zelst-Stams, W. A. / van Oijen, M. G. / Laheij, R. J. / Jansen, J. B. / Hoogerbrugge, N. et al. | 2011
- 1578
-
Efficacy of a leptin receptor antagonist peptide in a mouse model of triple-negative breast cancerOtvos, L. / Kovalszky, I. / Riolfi, M. / Ferla, R. / Olah, J. / Sztodola, A. / Nama, K. / Molino, A. / Piubello, Q. / Wade, J. D. et al. | 2011
- 1585
-
p62/SQSTM1 involved in cisplatin resistance in human ovarian cancer cells by clearing ubiquitinated proteinsYu, H. / Su, J. / Xu, Y. / Kang, J. / Li, H. / Zhang, L. / Yi, H. / Xiang, X. / Liu, F. / Sun, L. et al. | 2011
- 1595
-
VEGF-SPECT with 111In-bevacizumab in stage III/IV melanoma patientsNagengast, W. B. / Hooge, M. N. / van Straten, E. M. / Kruijff, S. / Brouwers, A. H. / den Dunnen, W. F. / de Jong, J. R. / Hollema, H. / Dierckx, R. A. / Mulder, N. H. et al. | 2011
- 1603
-
Under usage of zoledronic acid in non-small cell lung cancer patients with metastatic bone disease - a short communicationCalderone, R. / Nimako, K. / Leary, A. / Popat, S. / O'Brien, M. E. et al. | 2011
- 1606
-
Body mass index and risk of multiple myeloma: A meta-analysis of prospective studiesWallin, A. / Larsson, S. C. et al. | 2011
- 1616
-
Never-ageing cellular senescenceOgrunc, M. / Fagagna, F. d. et al. | 2011
- 1623
-
Hormone replacement therapy and women with premature menopause - A cancer survivorship issueKing, J. / Wynne, C. H. / Assersohn, L. / Jones, A. et al. | 2011
- 1633
-
Cost-effectiveness of primary HPV screening for cervical cancer in Germany - a decision analysisSroczynski, G. / Schnell-Inderst, P. / Muhlberger, N. / Lang, K. / Aidelsburger, P. / Wasem, J. / Mittendorf, T. / Engel, J. / Hillemanns, P. / Petry, K. U. et al. | 2011
- 1647
-
Effect of a misspecification of response rates on type I and type II errors, in a phase II Simon designBaey, C. / Le Deley, M. C. et al. | 2011
- 1653
-
A randomised phase II study of docetaxel/oxaliplatin and docetaxel in patients with previously treated non-small cell lung cancer: An Alpe-Adria Thoracic Oncology Multidisciplinary group trial (ATOM 019)Belvedere, O. / Follador, A. / Rossetto, C. / Merlo, V. / Defferrari, C. / Sibau, A. M. / Aita, M. / Dal Bello, M. G. / Meduri, S. / Gaiardo, M. et al. | 2011
- 1660
-
The use of 24-h ambulatory blood pressure monitoring (ABPM) during the first cycle of sunitinib improves the diagnostic accuracy and management of hypertension in patients with advanced renal cancerBamias, A. / Manios, E. / Karadimou, A. / Michas, F. / Lainakis, G. / Constantinidis, C. / Deliveliotis, C. / Zakopoulos, N. / Dimopoulos, M. A. et al. | 2011
- 1669
-
Relationship between CCL5 and transforming growth factor-b1 (TGFb1) in breast cancerHartmann, M. C. / Dwyer, R. M. / Costello, M. / Potter, S. M. / Curran, C. / Hennessy, E. / Newell, J. / Griffin, D. G. / Kerin, M. J. et al. | 2011
- 1676
-
Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: A phase III-study from the German CONKO-study groupPelzer, U. / Schwaner, I. / Stieler, J. / Adler, M. / Seraphin, J. / Dorken, B. / Riess, H. / Oettle, H. et al. | 2011
- 1682
-
Clinical and genetic factors associated with nausea and vomiting in cancer patients receiving opioidsLaugsand, E. A. / Fladvad, T. / Skorpen, F. / Maltoni, M. / Kaasa, S. / Fayers, P. / Klepstad, P. et al. | 2011
- 1692
-
Gastrointestinal stromal tumours in children and young adults: A clinicopathologic series with long-term follow-up from the database of the Cooperative Weichteilsarkom Studiengruppe (CWS)Benesch, M. / Leuschner, I. / Wardelmann, E. / Thielen, M. / Schmid, I. / Kontny, U. / Ebetsberger, G. / Frey, E. / Graf, N. / Schneider, D. T. et al. | 2011
- 1699
-
GWAS-identified colorectal cancer susceptibility locus associates with disease prognosisXing, J. / Myers, R. E. / He, X. / Qu, F. / Zhou, F. / Ma, X. / Hyslop, T. / Bao, G. / Wan, S. / Yang, H. et al. | 2011
- 1708
-
High serum angiogenin at diagnosis predicts for failure on long-term treatment response and for poor overall survival in non-Hodgkin lymphomaFang, S. / Repo, H. / Joensuu, H. / Orpana, A. / Salven, P. et al. | 2011
- 1717
-
Insulin-like growth factor-I receptor (IGF-IR) targeting with monoclonal antibody cixutumumab (IMC-A12) inhibits IGF-I action in endometrial cancer cellsAttias-Geva, Z. / Bentov, I. / Ludwig, D. L. / Fishman, A. / Bruchim, I. / Werner, H. et al. | 2011
- 1727
-
Adrenomedullin expression and regulation in human glioblastoma, cultured human glioblastoma cell lines and pilocytic astrocytomaMetellus, P. / Voutsinos-Porche, B. / Nanni-Metellus, I. / Colin, C. / Fina, F. / Berenguer, C. / Dussault, N. / Boudouresque, F. / Loundou, A. / Intagliata, D. et al. | 2011
- 1736
-
An antibody-cytotoxic conjugate, BIIB015, is a new targeted therapy for Cripto positive tumoursKelly, R. K. / Olson, D. L. / Sun, Y. / Wen, D. / Wortham, K. A. / Antognetti, G. / Cheung, A. E. / Orozco, O. E. / Yang, L. / Bailly, V. et al. | 2011
- 1747
-
PERIOD1 (PER1) has anti-apoptotic effects, and PER3 has pro-apoptotic effects during cisplatin (CDDP) treatment in human gingival cancer CA9-22 cellsSato, F. / Wu, Y. / Bhawal, U. K. / Liu, Y. / Imaizumi, T. / Morohashi, S. / Kato, Y. / Kijima, H. et al. | 2011
- 1759
-
Is it time to abandon complete blinded independent central radiological evaluation of progression in registration trials?Pignatti, F. / Hemmings, R. / Jonsson, B. et al. | 2011
- 1763
-
Research outcomes and recommendations for the assessment of progression in cancer clinical trials from a PhRMA working groupStone, A. M. / Bushnell, W. / Denne, J. / Sargent, D. J. / Amit, O. / Chen, C. / Bailey-Iacona, R. / Helterbrand, J. / Williams, G. et al. | 2011
- 1772
-
Blinded independent central review of progression in cancer clinical trials: Results from a meta-analysisAmit, O. / Mannino, F. / Stone, A. M. / Bushnell, W. / Denne, J. / Helterbrand, J. / Burger, H. U. et al. | 2011
- 1779
-
Association between c-myc amplification and pathological complete response to neoadjuvant chemotherapy in breast cancerYasojima, H. / Shimomura, A. / Naoi, Y. / Kishi, K. / Baba, Y. / Shimazu, K. / Nakayama, T. / Kim, S. J. / Tamaki, Y. / Noguchi, S. et al. | 2011
- 1789
-
Molecular classification of hepatocellular carcinoma anno 2011van Malenstein, H. / van Pelt, J. / Verslype, C. et al. | 2011
- 1798
-
Impact of chemotherapy on health status and symptom burden of colon cancer survivors: A population-based studyThong, M. S. / Mols, F. / Lemmens, V. E. / Creemers, G. J. / Slooter, G. D. / van de Poll-Franse, L. V. et al. | 2011
- 1808
-
A U-shaped relationship between plasma folate and pancreatic cancer risk in the European Prospective Investigation into Cancer and NutritionChuang, S. C. / Stolzenberg-Solomon, R. / Ueland, P. M. / Vollset, S. E. / Midttun, O. / Olsen, A. / Tjonneland, A. / Overvad, K. / Boutron-Ruault, M. C. / Morois, S. et al. | 2011
- 1817
-
DNA methyltransferase 1 as a predictive biomarker and potential therapeutic target for chemotherapy in gastric cancerMutze, K. / Langer, R. / Schumacher, F. / Becker, K. / Ott, K. / Novotny, A. / Hapfelmeier, A. / Hofler, H. / Keller, G. et al. | 2011
- 1826
-
Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysisClarke, S. J. / Yip, S. / Brown, C. / van Hazel, G. A. / Ransom, D. T. / Goldstein, D. / Jeffrey, G. M. / Tebbutt, N. C. / Buck, M. / Lowenthal, R. M. et al. | 2011
- 1837
-
Loss of lamin A/C expression in stage II and III colon cancer is associated with disease recurrenceBelt, E. J. / Fijneman, R. J. / van den Berg, E. G. / Bril, H. / Delis-van Diemen, P. M. / Tijssen, M. / van Essen, H. F. / de Lange-de Klerk, E. S. / Belien, J. A. / Stockmann, H. B. et al. | 2011
- 1846
-
Antiangiogenic agents and endothelin antagonists in advanced castration resistant prostate cancerMerino, M. / Pinto, A. / Gonzalez, R. / Espinosa, E. et al. | 2011
- 1852
-
Childhood cancer survival in Ireland: Temporal, regional and deprivation-related patternsWalsh, P. M. / Byrne, J. / Capra, M. / Comber, H. et al. | 2011
- 1863
-
A comprehensive study of psychometric properties of the Edmonton Symptom Assessment System (ESAS) in Spanish advanced cancer patientsCarvajal, A. / Centeno, C. / Watson, R. / Bruera, E. et al. | 2011
- 1873
-
Magnetic functionalised carbon nanotubes as drug vehicles for cancer lymph node metastasis treatmentYang, F. / Jin, C. / Yang, D. / Jiang, Y. / Li, J. / Di, Y. / Hu, J. / Wang, C. / Ni, Q. / Fu, D. et al. | 2011
- 1883
-
Cytokine analysis as a tool to understand tumour-host interaction in ovarian cancerYigit, R. / Figdor, C. G. / Zusterzeel, P. L. / Pots, J. M. / Torensma, R. / Massuger, L. F. et al. | 2011
- 1890
-
Seleno-cyclodextrin sensitises human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-kB suppressionLin, T. / Ding, Z. / Li, N. / Xu, J. / Luo, G. / Liu, J. / Shen, J. et al. | 2011
- 1908
-
IL-20 is epigenetically regulated in NSCLC and down regulates the expression of VEGFBaird, A. M. / Gray, S. G. / O'Byrne, K. J. et al. | 2011
- 1919
-
Risk factors for metachronous contralateral breast cancer suggest two aetiological pathwaysVichapat, V. / Gillett, C. / Fentiman, I. S. / Tutt, A. / Holmberg, L. / Luchtenborg, M. et al. | 2011
- 1928
-
Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studiesBen, Q. / Xu, M. / Ning, X. / Liu, J. / Hong, S. / Huang, W. / Zhang, H. / Li, Z. et al. | 2011
- 1938
-
Type I interferons as radiosensitisers for pancreatic cancerMorak, M. J. / van Koetsveld, P. M. / Kanaar, R. / Hofland, L. J. / van Eijck, C. H. et al. | 2011
- 1946
-
Differential gene expression signatures between colorectal cancers with and without KRAS mutations: Crosstalk between the KRAS pathway and other signalling pathwaysWatanabe, T. / Kobunai, T. / Yamamoto, Y. / Matsuda, K. / Ishihara, S. / Nozawa, K. / Iinuma, H. / Ikeuchi, H. / Eshima, K. et al. | 2011
- 1955
-
Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: A retrospective examinationKeizman, D. / Huang, P. / Eisenberger, M. A. / Pili, R. / Kim, J. J. / Antonarakis, E. S. / Hammers, H. / Carducci, M. A. et al. | 2011
- 1962
-
CYP1A1*2A polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI and its combined effects with EGFR intron 1 (CA)n polymorphismNie, Q. / Yang, X. n. / An, S. j. / Zhang, X. c. / Yang, J. j. / Zhong, W. z. / Liao, R. q. / Chen, Z. h. / Su, J. / Xie, Z. et al. | 2011
- 1971
-
Enhanced detection of BRAF-mutants by pre-PCR cleavage of wild-type sequences revealed circulating melanoma cells heterogeneityFusi, A. / Berdel, R. / Havemann, S. / Nonnenmacher, A. / Keilholz, U. et al. | 2011
- 1977
-
A first prospective population-based analysis investigating the actual practice of melanoma diagnosis, treatment and follow-upLivingstone, E. / Windemuth-Kieselbach, C. / Eigentler, T. K. / Rompel, R. / Trefzer, U. / Nashan, D. / Rotterdam, S. / Ugurel, S. / Schadendorf, D. et al. | 2011
- 1990
-
Prognostic value of the multidrug resistance transporter ABCG2 gene polymorphisms in Chinese patients with de novo acute leukaemiaWang, F. / Liang, Y. j. / Wu, X. p. / Chen, L. m. / To, K. K. / Dai, C. l. / Yan, Y. y. / Wang, Y. s. / Tong, X. z. / Fu, L. w. et al. | 2011
- 2000
-
The use of liposomal anthracycline analogues for childhood malignancies: A systematic reviewSieswerda, E. / Kremer, L. C. / Caron, H. N. / van Dalen, E. C. et al. | 2011
- 2009
-
The impact of short-term psycho-oncological interventions on the psychological outcome of cancer patients of a surgical-oncology department - A randomised controlled studyGoerling, U. / Foerg, A. / Sander, S. / Schramm, N. / Schlag, P. M. et al. | 2011
- 2015
-
Monocyte number associated with incident cancer and mortality in middle-aged and elderly community-dwelling DanesSajadieh, A. / Mouridsen, M. R. / Selmer, C. / Intzilakis, T. / Nielsen, O. W. / Haugaard, S. B. et al. | 2011
- 2023
-
Better survival in patients with metastasised kidney cancer after nephrectomy: A population-based study in the NetherlandsAben, K. K. / Heskamp, S. / Janssen-Heijnen, M. L. / Koldewijn, E. L. / van Herpen, C. M. / Kiemeney, L. A. / Oosterwijk, E. / van Spronsen, D. J. et al. | 2011
- 2033
-
Gamma-glutamyltransferase and risk of cancer in a cohort of 545,460 persons - the Swedish AMORIS studyVan Hemelrijck, M. / Jassem, W. / Walldius, G. / Fentiman, I. S. / Hammar, N. / Lambe, M. / Garmo, H. / Jungner, I. / Holmberg, L. et al. | 2011
- 2042
-
Apigenin affects leptin/leptin receptor pathway and induces cell apoptosis in lung adenocarcinoma cell lineBruno, A. / Siena, L. / Gerbino, S. / Ferraro, M. / Chanez, P. / Giammanco, M. / Gjomarkaj, M. / Pace, E. et al. | 2011
- 2052
-
Preclinical in vitro and in vivo evaluation of the potent and specific cyclin-dependent kinase 2 inhibitor NU6102 and a water soluble prodrug NU6301Thomas, H. D. / Wang, L. Z. / Roche, C. / Bentley, J. / Cheng, Y. / Hardcastle, I. R. / Golding, B. T. / Griffin, R. J. / Curtin, N. J. / Newell, D. R. et al. | 2011
- 2060
-
Suppression of retinoid X receptor alpha and aberrant b-catenin expression significantly associates with progression of colorectal carcinomaZhang, F. / Meng, F. / Li, H. / Dong, Y. / Yang, W. / Han, A. et al. | 2011
- 2068
-
Genetic and epigenetic control of UNC5C expression in human renal cell carcinomaLv, D. / Zhao, W. / Dong, D. / Qian, X. P. / Zhang, Y. / Tian, X. J. / Zhang, J. et al. | 2011
- 2077
-
The European Academy of Cancer Sciences| 2011
- 2082
-
What makes a good pathology report?Nobile, A. / Treboux, A. / Delaloye, J. F. / Zaman, K. / Jeanneret-Sozzi, W. / Schaefer, S. C. / Lehr, H. A. et al. | 2011
- 2084
-
Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patientsKong, X. / Moran, M. S. / Zhang, N. / Haffty, B. / Yang, Q. et al. | 2011
- 2091
-
A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancerAmadori, D. / Milandri, C. / Comella, G. / Saracchini, S. / Salvagni, S. / Barone, C. / Bordonaro, R. / Gebbia, V. / Barbato, A. / Serra, P. et al. | 2011
- 2099
-
The role of ipsilateral breast radiotherapy in management of occult primary breast cancer presenting as axillary lymphadenopathyBarton, S. R. / Smith, I. E. / Kirby, A. M. / Ashley, S. / Walsh, G. / Parton, M. et al. | 2011
- 2107
-
Whole-body diffusion-weighted magnetic resonance imaging: Current evidence in oncology and potential role in colorectal cancer stagingLambregts, D. M. / Maas, M. / Cappendijk, V. C. / Prompers, L. M. / Mottaghy, F. M. / Beets, G. L. / Beets-Tan, R. G. et al. | 2011
- 2117
-
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinomaKudo, M. / Imanaka, K. / Chida, N. / Nakachi, K. / Tak, W. Y. / Takayama, T. / Yoon, J. H. / Hori, T. / Kumada, H. / Hayashi, N. et al. | 2011
- 2128
-
Oral disease and risk of oesophageal and gastric cancer in a nationwide nested case-control study in SwedenLjung, R. / Martin, L. / Lagergren, J. et al. | 2011
- 2133
-
Management of metastatic castration-resistant prostate cancer after first-line docetaxelHarrington, J. A. / Jones, R. J. et al. | 2011
- 2143
-
Re-evaluating the role of palliative radiotherapy in malignant pleural mesotheliomaJenkins, P. / Milliner, R. / Salmon, C. et al. | 2011
- 2150
-
New drugs in melanoma: It's a whole new worldEggermont, A. M. / Robert, C. et al. | 2011
- 2158
-
Laparoscopic hysterectomy is preferred over laparotomy in early endometrial cancer patients, however not cost effective in the very obeseBijen, C. B. / de Bock, G. H. / Vermeulen, K. M. / Arts, H. J. / ter Brugge, H. G. / van der Sijde, R. / Kraayenbrink, A. A. / Bongers, M. Y. / van der Zee, A. G. / Mourits, M. J. et al. | 2011
- 2166
-
Reduced miR-100 expression in cervical cancer and precursors and its carcinogenic effect through targeting PLK1 proteinLi, B. H. / Zhou, J. S. / Ye, F. / Cheng, X. D. / Zhou, C. Y. / Lu, W. G. / Xie, X. et al. | 2011
- 2175
-
Place of death and hospital care for children who died of cancer in England, 1999-2006Shah, A. / Diggens, N. / Stiller, C. / Murphy, D. / Passmore, J. / Murphy, M. F. et al. | 2011
- 2182
-
Factors affecting treatment choices in paediatric palliative care: Comparing parents and health professionalsTomlinson, D. / Bartels, U. / Hendershot, E. / Maloney, A. M. / Ethier, M. C. / Sung, L. et al. | 2011
- 2188
-
The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: Scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohortsvan de Poll-Franse, L. V. / Horevoorts, N. / Eenbergen, M. v. / Denollet, J. / Roukema, J. A. / Aaronson, N. K. / Vingerhoets, A. / Coebergh, J. W. / de Vries, J. / Essink-Bot, M. L. et al. | 2011
- 2195
-
Psychiatric treatment in men with prostate cancer - Results from a Nation-wide, population-based cohort study from PCBaSe SwedenBill-Axelson, A. / Garmo, H. / Nyberg, U. / Lambe, M. / Bratt, O. / Stattin, P. / Adolfsson, J. / Steineck, G. et al. | 2011
- 2202
-
Choosing the relative survival method for cancer survival estimationHakulinen, T. / Seppa, K. / Lambert, P. C. et al. | 2011
- 2211
-
Levels of acute health service use among cancer survivors in the United KingdomMaddams, J. / Utley, M. / Moller, H. et al. | 2011
- 2221
-
Identification of a novel cell binding site of periostin involved in tumour growthOrecchia, P. / Conte, R. / Balza, E. / Castellani, P. / Borsi, L. / Zardi, L. / Mingari, M. C. / Carnemolla, B. et al. | 2011
- 2230
-
The inhibition of pancreatic cancer invasion-metastasis cascade in both cellular signal and blood coagulation cascade of tissue factor by its neutralisation antibodySaito, Y. / Hashimoto, Y. / Kuroda, J. i. / Yasunaga, M. / Koga, Y. / Takahashi, A. / Matsumura, Y. et al. | 2011
- 2240
-
Curcumin improves MMC-based chemotherapy by simultaneously sensitising cancer cells to MMC and reducing MMC-associated side-effectsZhou, Q. M. / Wang, X. F. / Liu, X. J. / Zhang, H. / Lu, Y. Y. / Huang, S. / Su, S. B. et al. | 2011
- 2249
-
Natural history, management and pharmacokinetics of Everolimus-induced-oral ulcers: Insights into compliance issuesFerte, C. / Paci, A. / Zizi, M. / Gonzales, D. B. / Goubar, A. / Gomez-Roca, C. / Massard, C. / Sahmoud, T. / Andre, F. / Soria, J. C. et al. | 2011
- 2256
-
Phase I, open-label, multicentre, dose-escalation, pharmacokinetic and pharmacodynamic trial of the oral aurora kinase inhibitor PF-03814735 in advanced solid tumoursSchoffski, P. / Jones, S. F. / Dumez, H. / Infante, J. R. / Van Mieghem, E. / Fowst, C. / Gerletti, P. / Xu, H. / Jakubczak, J. L. / English, P. A. et al. | 2011
- 2265
-
Determining circulating endothelial cells using CellSearch system during preoperative systemic chemotherapy in breast cancer patientsAli, A. M. / Ueno, T. / Tanaka, S. / Takada, M. / Ishiguro, H. / Abdellah, A. Z. / Toi, M. et al. | 2011
- 2273
-
Trastuzumab beyond progression: Overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancervon Minckwitz, G. / Schwedler, K. / Schmidt, M. / Barinoff, J. / Mundhenke, C. / Cufer, T. / Maartense, E. / de Jongh, F. E. / Baumann, K. H. / Bischoff, J. et al. | 2011
- 2282
-
Hepatic resection for metastatic breast cancer: A systematic reviewChua, T. C. / Saxena, A. / Liauw, W. / Chu, F. / Morris, D. L. et al. | 2011
- 2291
-
Effectiveness and cost-effectiveness of peri-operative versus post-operative chemotherapy for resectable colorectal liver metastasesErcolani, G. / Cucchetti, A. / Cescon, M. / Peri, E. / Brandi, G. / Gaudio, M. D. / Ravaioli, M. / Zanello, M. / Pinna, A. D. et al. | 2011
- 2299
-
Overexpression of matrix metalloproteinase-12 (MMP-12) correlates with poor prognosis of hepatocellular carcinomaNg, K. T. / Qi, X. / Kong, K. L. / Cheung, B. Y. / Lo, C. M. / Poon, R. T. / Fan, S. T. / Man, K. et al. | 2011
- 2306
-
Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer - A randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)Thuss-Patience, P. C. / Kretzschmar, A. / Bichev, D. / Deist, T. / Hinke, A. / Breithaupt, K. / Dogan, Y. / Gebauer, B. / Schumacher, G. / Reichardt, P. et al. | 2011
- 2315
-
Clinical management of primary vulvar cancerWoelber, L. / Kock, L. / Gieseking, F. / Petersen, C. / Trillsch, F. / Choschzick, M. / Jaenicke, F. / Mahner, S. et al. | 2011
- 2322
-
Randomised phase II study of amrubicin as single agent or in combination with cisplatin versus cisplatin etoposide as first-line treatment in patients with extensive stage small cell lung cancer - EORTC 08062O'Brien, M. E. / Konopa, K. / Lorigan, P. / Bosquee, L. / Marshall, E. / Bustin, F. / Margerit, S. / Fink, C. / Stigt, J. A. / Dingemans, A. M. et al. | 2011
- 2331
-
A double-blind, randomised, placebo-controlled phase III intergroup study of gefitinib in patients with advanced NSCLC, non-progressing after first line platinum-based chemotherapy (EORTC 08021/ILCP 01/03)Gaafar, R. M. / Surmont, V. F. / Scagliotti, G. V. / Van Klaveren, R. J. / Papamichael, D. / Welch, J. J. / Hasan, B. / Torri, V. / van Meerbeeck, J. P. et al. | 2011
- 2341
-
Higher doses of opioids in patients who need palliative sedation prior to death: Cause or consequence?Oosten, A. W. / Oldenmenger, W. H. / van Zuylen, C. / Schmitz, P. I. / Bannink, M. / Lieverse, P. J. / Bromberg, J. E. / van der Rijt, C. C. et al. | 2011
- 2347
-
Pancreatoblastoma: A report from the European cooperative study group for paediatric rare tumours (EXPeRT)Bien, E. / Godzinski, J. / Dall'Igna, P. / Defachelles, A. S. / Stachowicz-Stencel, T. / Orbach, D. / Bisogno, G. / Cecchetto, G. / Warmann, S. / Ellerkamp, V. et al. | 2011
- 2353
-
RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathwaysFeng, Y. / Hu, J. / Ma, J. / Feng, K. / Zhang, X. / Yang, S. / Wang, W. / Zhang, J. / Zhang, Y. et al. | 2011
- 2364
-
EGFR gene copy number alteration is a better prognostic indicator than protein overexpression in oral tongue squamous cell carcinomasNakata, Y. / Uzawa, N. / Takahashi, K. I. / Sumino, J. / Michikawa, C. / Sato, H. / Sonoda, I. / Ohyama, Y. / Okada, N. / Amagasa, T. et al. | 2011
- 2373
-
Corrigendum to "Tumour-mediated TRAIL-Receptor expression indicates effective apoptotic depletion of infiltrating CD8+ immune cells in clinical colorectal cancer" [European Journal of Cancer 46 (12) (2010) 2314-2323]Grimm, M. / Kim, M. / Rosenwald, A. / von Raden, B. H. / Tsaur, I. / Meier, E. / Heemann, U. / Germer, C. T. / Gasser, M. / Waaga-Gasser, A. M. et al. | 2011
- 2375
-
Avoiding the zero sum game in global cancer policy: Beyond 2011 UN high level summitSullivan, R. / Purushotham, A. D. et al. | 2011
- 2381
-
Early stopping rules in oncology: Considerations for cliniciansMukherjee, S. D. / Goffin, J. R. / Taylor, V. / Anderson, K. K. / Pond, G. R. et al. | 2011
- 2387
-
Efficacy and safety of bevacizumab in combination with docetaxel for the first-line treatment of elderly patients with locally recurrent or metastatic breast cancer: Results from AVADOPivot, X. / Schneeweiss, A. / Verma, S. / Thomssen, C. / Passos-Coelho, J. L. / Benedetti, G. / Ciruelos, E. / von Moos, R. / Chang, H. T. / Duenne, A. A. et al. | 2011
- 2396
-
Myotax: A phase II trial of docetaxel plus non-pegylated liposomal doxorubicin as first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclinesCurtit, E. / Nouyrigat, P. / Dohollou, N. / Levy, E. / Lortholary, A. / Gligorov, J. / Facchini, T. / Jaubert, D. / Maille, N. / Pivot, X. et al. | 2011
- 2403
-
Colorectal cancer in HIV positive individuals: The immunological effects of treatmentAlfa-Wali, M. / Tait, D. / Allen-Mersh, T. / Tekkis, P. / Nelson, M. / Stebbing, J. / Antoniou, A. / Bower, M. et al. | 2011
- 2408
-
Hospital volume and survival in oesophagectomy and gastrectomy for cancerAnderson, O. / Ni, Z. / Moller, H. / Coupland, V. H. / Davies, E. A. / Allum, W. H. / Hanna, G. B. et al. | 2011
- 2415
-
Swedish Lung Cancer Radiation Study Group: Predictive value of histology for radiotherapy response in patients with non-small cell lung cancerHolgersson, G. / Bergstrom, S. / Bergqvist, M. / Nyman, J. / Hoye, E. / Helsing, M. / Friesland, S. / Holgersson, M. / Birath, E. / Ekman, S. et al. | 2011
- 2422
-
Body mass index and risk of non-Hodgkin's and Hodgkin's lymphoma: A meta-analysis of prospective studiesLarsson, S. C. / Wolk, A. et al. | 2011
- 2431
-
Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?Anninga, J. K. / Gelderblom, H. / Fiocco, M. / Kroep, J. R. / Taminiau, A. H. / Hogendoorn, P. C. / Egeler, R. M. et al. | 2011
- 2446
-
A prospective association between quality of life and risk for cancerFlensborg-Madsen, T. / Johansen, C. / Gronbaek, M. / Mortensen, E. L. et al. | 2011
- 2453
-
Systolic and diastolic dysfunction in long-term adult survivors of childhood cancerBrouwer, C. A. / Postma, A. / Vonk, J. M. / Zwart, N. / van den Berg, M. P. / Bink-Boelkens, M. T. / Dolsma, W. V. / Smit, A. J. / de Vries, E. G. / Tissing, W. J. et al. | 2011
- 2463
-
How to switch from morphine or oxycodone to methadone in cancer patients? A randomised clinical phase II trialMoksnes, K. / Dale, O. / Rosland, J. H. / Paulsen, O. / Klepstad, P. / Kaasa, S. et al. | 2011
- 2471
-
Death Receptor 5 and cellular FLICE-inhibitory protein regulate pemetrexed-induced apoptosis in human lung cancer cellsSu, L. / Liu, G. / Hao, X. / Zhong, N. / Zhong, D. / Liu, X. / Singhal, S. et al. | 2011
- 2479
-
MicroRNA-21 suppression impedes medulloblastoma cell migrationGrunder, E. / D'Ambrosio, R. / Fiaschetti, G. / Abela, L. / Arcaro, A. / Zuzak, T. / Ohgaki, H. / Lv, S. Q. / Shalaby, T. / Grotzer, M. et al. | 2011
- 2491
-
Removal notice to "Nimotuzumab in combination with docetaxel and carboplatin as treatment for advanced non-small-cell-lung-cancer" EJC Supp 9 (2011) 23Qi, D. / Wang, Q. / Huang, C. / Li, Y. / Yang, Y. / Cui, Y. / Xin, L. / Xu, J. / Wang, H. / Zheng, J. et al. | 2011
- 2493
-
Rare cancers are not so rare: The rare cancer burden in EuropeGatta, G. / van der Zwan, J. M. / Casali, P. G. / Siesling, S. / Dei Tos, A. P. / Kunkler, I. / Otter, R. / Licitra, L. / Mallone, S. / Tavilla, A. et al. | 2011
- 2512
-
Tumour growth rates and RECIST criteria in early drug developmentGomez-Roca, C. / Koscielny, S. / Ribrag, V. / Dromain, C. / Marzouk, I. / Bidault, F. / Bahleda, R. / Ferte, C. / Massard, C. / Soria, J. C. et al. | 2011
- 2517
-
The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognosesCampbell, H. E. / Epstein, D. / Bloomfield, D. / Griffin, S. / Manca, A. / Yarnold, J. / Bliss, J. / Johnson, L. / Earl, H. / Poole, C. et al. | 2011
- 2531
-
Incidental findings on brain Magnetic Resonance Imaging in long-term survivors of breast cancer treated with adjuvant chemotherapyKoppelmans, V. / Schagen, S. B. / Poels, M. M. / Boogerd, W. / Seynaeve, C. / Lugt, A. v. / Breteler, M. M. et al. | 2011
- 2537
-
Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancerHan, H. S. / Reis, I. M. / Zhao, W. / Kuroi, K. / Toi, M. / Suzuki, E. / Syme, R. / Chow, L. / Yip, A. Y. / Gluck, S. et al. | 2011
- 2546
-
Meta-analysis of CHEK2 1100delC variant and colorectal cancer susceptibilityXiang, H. p. / Geng, X. p. / Ge, W. w. / Li, H. et al. | 2011
- 2552
-
miR-429 Modulates the expression of c-myc in human gastric carcinoma cellsSun, T. / Wang, C. / Xing, J. / Wu, D. et al. | 2011
- 2560
-
Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapySimkens, L. H. / Koopman, M. / Mol, L. / Veldhuis, G. J. / Ten Bokkel Huinink, D. / Muller, E. W. / Derleyn, V. A. / Teerenstra, S. / Punt, C. J. et al. | 2011
- 2568
-
Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinomaChun, Y. H. / Kim, S. U. / Park, J. Y. / Kim, D. Y. / Han, K. H. / Chon, C. Y. / Kim, B. K. / Choi, G. H. / Kim, K. S. / Choi, J. S. et al. | 2011
- 2576
-
Angiogenesis: A prognostic determinant in pancreatic cancer?van der Zee, J. A. / van Eijck, C. H. / Hop, W. C. / van Dekken, H. / Dicheva, B. M. / Seynhaeve, A. L. / Koning, G. A. / Eggermont, A. M. / ten Hagen, T. L. et al. | 2011
- 2585
-
The pituitary-Leydig cell axis before and after orchiectomy in patients with stage I testicular cancerBandak, M. / Aksglaede, L. / Juul, A. / Rorth, M. / Daugaard, G. et al. | 2011
- 2592
-
Key predictive factors of axitinib (AG-013736)-induced proteinuria and efficacy: A phase II study in Japanese patients with cytokine-refractory metastatic renal cell CarcinomaTomita, Y. / Uemura, H. / Fujimoto, H. / Kanayama, H. o. / Shinohara, N. / Nakazawa, H. / Imai, K. / Umeyama, Y. / Ozono, S. / Naito, S. et al. | 2011
- 2603
-
Retreatment with erlotinib: Regain of TKI sensitivity following a drug holiday for patients with NSCLC who initially responded to EGFR-TKI treatmentBecker, A. / Crombag, L. / Heideman, D. A. / Thunnissen, F. B. / van Wijk, A. W. / Postmus, P. E. / Smit, E. F. et al. | 2011
- 2607
-
Hormonal and reproductive factors in relation to melanoma in women: Current review and meta-analysisGandini, S. / Iodice, S. / Koomen, E. / Pietro, A. D. / Sera, F. / Caini, S. et al. | 2011
- 2618
-
Genetic polymorphisms in DNA repair and oxidative stress pathways associated with malignant melanoma susceptibilityIbarrola-Villava, M. / Pena-Chilet, M. / Fernandez, L. P. / Aviles, J. A. / Mayor, M. / Martin-Gonzalez, M. / Gomez-Fernandez, C. / Casado, B. / Lazaro, P. / Lluch, A. et al. | 2011
- 2626
-
Estimating expected survival probabilities for relative survival analysis - Exploring the impact of including cancer patient mortality in the calculationsTalback, M. / Dickman, P. W. et al. | 2011
- 2633
-
A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome StudyProctor, M. J. / Morrison, D. S. / Talwar, D. / Balmer, S. M. / Fletcher, C. D. / O'Reilly, D. S. / Foulis, A. K. / Horgan, P. G. / McMillan, D. C. et al. | 2011
- 2642
-
EW-7195, a novel inhibitor of ALK5 kinase inhibits EMT and breast cancer metastasis to lungPark, C. Y. / Son, J. Y. / Jin, C. H. / Nam, J. S. / Kim, D. K. / Sheen, Y. Y. et al. | 2011
- 2654
-
Growth of the pancreatic cancer cell line PANC-1 is inhibited by protein phosphatase 2A inhibitors through overactivation of the c-Jun N-terminal kinase pathwayLi, W. / Chen, Z. / Gong, F. R. / Zong, Y. / Chen, K. / Li, D. M. / Yin, H. / Duan, W. M. / Miao, Y. / Tao, M. et al. | 2011
- 2665
-
Frequency and severity of skin reactions in patients with breast cancer undergoing adjuvant radiotherapy, the usefulness of two assessment instruments - A pilot studySharp, L. / Johansson, H. / Landin, Y. / Moegelin, I. M. / Bergenmar, M. et al. | 2011
- 2673
-
Sensitivity to previous irinotecan treatment does not predict the efficacy of combination chemotherapy with cetuximab plus irinotecan for wild-type KRAS metastatic colorectal cancerShitara, K. / Ura, T. / Matsuo, K. / Takahari, D. / Yokota, T. / Yuki, S. / Yoshida, M. / Utsunomiya, S. / Sato, Y. / Yamaura, H. et al. | 2011
- 2681
-
Modern insights into hepatic arterial infusion for liver metastases from colorectal cancerBouchahda, M. / Levi, F. / Adam, R. / Rougier, P. et al. | 2011
- 2691
-
Treatment with curative intent of stage III non-small cell lung cancer patients of 75years: A prospective population-based studyWanders, R. / Steevens, J. / Botterweck, A. / Dingemans, A. M. / Reymen, B. / Baardwijk, A. v. / Borger, J. / Bootsma, G. / Pitz, C. / Lunde, R. et al. | 2011
- 2698
-
False-positive screening results in the European randomized study of screening for prostate cancerKilpelainen, T. P. / Tammela, T. L. / Roobol, M. / Hugosson, J. / Ciatto, S. / Nelen, V. / Moss, S. / Maattanen, L. / Auvinen, A. et al. | 2011
- 2706
-
Phase 2 trial of linifanib (ABT-869) in patients with advanced renal cell cancer after sunitinib failureTannir, N. M. / Wong, Y. N. / Kollmannsberger, C. K. / Ernstoff, M. S. / Perry, D. J. / Appleman, L. J. / Posadas, E. M. / Cho, D. / Choueiri, T. K. / Coates, A. et al. | 2011
- 2715
-
Gene expression analysis of blastemal component reveals genes associated with relapse mechanism in Wilms tumourMaschietto, M. / Piccoli, F. S. / Costa, C. M. / Camargo, L. P. / Neves, J. I. / Grundy, P. E. / Brentani, H. / Soares, F. A. / Camargo, B. d. / Carraro, D. M. et al. | 2011
- 2723
-
Malignant peripheral nerve sheath tumours in NF1: Improved survival in women and in recent yearsIngham, S. / Huson, S. M. / Moran, A. / Wylie, J. / Leahy, M. / Evans, D. G. et al. | 2011
- 2729
-
Radiochemotherapy versus surgery plus radio(chemo)therapy for stage T3/T4 larynx and hypopharynx cancer - Results of a matched-pair analysisRades, D. / Schroeder, U. / Bajrovic, A. / Schild, S. E. et al. | 2011
- 2735
-
End of life care in adolescents and young adults with cancer: Experience of the adolescent unit of the Institut Gustave RoussyCohen-Gogo, S. / Marioni, G. / Laurent, S. / Gaspar, N. / Semeraro, M. / Gabolde, M. / Dufour, C. / Valteau-Couanet, D. / Brugieres, L. et al. | 2011
- 2742
-
The EORTC 10041/BIG 03-04 MINDACT trial is feasible: Results of the pilot phaseRutgers, E. / Piccart-Gebhart, M. J. / Bogaerts, J. / Delaloge, S. / Veer, L. V. / Rubio, I. T. / Viale, G. / Thompson, A. M. / Passalacqua, R. / Nitz, U. et al. | 2011
- 2750
-
New insights of mitochondria reactive oxygen species generation and cell apoptosis induced by low dose photodynamic therapyZhao, H. / Xing, D. / Chen, Q. et al. | 2011
- 2762
-
Referees 2011| 2011
- S1
-
SP 128 KRAS mutations in colorectal cancer: lessons learned and future progressEckhardt, S. G. et al. | 2011
- S2
-
SP 113 Translating molecular imaging agents into phase 3 trialsJacobs, P. et al. | 2011
- S3
-
4 EONS Distinguished Merit Award The Impact of a Maternal Cancer Diagnosis on School-age ChildrenFurlong, E. et al. | 2011
- S4
-
Chairpersons introductionJohnston, S. R. et al. | 2011
- S4
-
7 INVITED Possible Intervention Strategies to Reduce Radiation-induced Heart DiseaseHovinq, S. / Seemann, I. / Gabriels, K. / Visser, N. L. / te Poele, J. A. / Heeneman, S. / Daemen, M. J. / Stewart, F. A. et al. | 2011
- S5
-
14 INVITED Deregulated tRNA Expression in CancerWhite, R. J. et al. | 2011
- S6
-
18 INVITED Imaging of Hypoxia (HIF-1a) With Genetically Encoded Reporter GenesSerganova, I. / Blasberq, R. et al. | 2011
- S6
-
The role of surgery in metastatic breast cancerRuiterkamp, J. / Ernst, M. F. et al. | 2011
- S6
-
SP 112 Integration of metabolic imaging (PET CT) into clinical trialsWeber, W. et al. | 2011
- S7
-
21 INVITED The Epidemiology of Childhood Cancer SurvivorsHaupt, R. / Pisani, P. / Garwicz, S. / Hawkins, M. / Skinner, R. / Hjorth, L. et al. | 2011
- S8
-
OP 29 Development of a genomic-clinical classifier model for predicting clinical recurrence in patients with localized prostate cancerJenkins, R. / Crisan, A. / Erho, N. / Ballman, K. V. / Bergstralh, E. J. / Fink, S. R. / Kollmeyer, T. M. / Buerki, C. / Black, P. C. / Davicioni, E. et al. | 2011
- S9
-
OP 75 An unbiased shRNA based lentiviral screen identifies tyrosine kinases that are important for survival and radioresistance in Head and Neck Squamous Cell CarcinomaVan Limbergen, E. J. / Zabrocki, P. / Porcu, M. / Hauben, E. / Cools, J. / Nuyts, S. et al. | 2011
- S9
-
29 INVITED Peritoneal Carcinomatosis of Colorectal OriginQuenet, F. / Escayola, C. / Viot, A. / Mehta, S. / Torrent, J. J. et al. | 2011
- S11
-
38 INVITED Robotic Surgery - Opportunities and Issues for NursingMartin, S. et al. | 2011
- S11
-
PP 36 Highly-specific and sensitive hydrolysis probe-based real-time PCR detection of epidermal growth factor receptor variant III in oral squamous cell carcinomaBose, P. / McIntyre, J. B. / Klimowicz, A. C. / Brockton, N. T. / Petrilllo, S. / Matthews, W. / Easaw, J. / Magliocco, A. / Dort, J. C. et al. | 2011
- S12
-
42 INVITED Late Functional Outcome SurgeryDietz, A. et al. | 2011
- S12
-
PP 83 Gene expression profiling of circulating tumor cells in breast cancerCappelletti, V. / Fina, E. / Miodini, P. / Callari, M. / Musella, V. / Agresti, R. / Moliterni, A. / Daidone, M. G. et al. | 2011
- S13
-
46 INVITED For Sentinel Node Positive Patients - is Complete Lymph Node Resection Still the Standard of Care?Nieweq, O. et al. | 2011
- S13
-
PP 33 Detection of prostate cancer by plasma proteome profiling based on matrix-assisted laser desorption/ionization time-of-flight mass spectrometryChernyaev, V. / Shevchenko, V. E. / Arnotskaya, N. E. / Chernyaev, V. A. / Matveev, V. B. et al. | 2011
- S14
-
PP 4 Identification of specific biomarkers for glioma-initiating cells and glioma tumorsClement-Schatlo, V. / Tenan, M. / Schatlo, B. / Marino, D. / Burkhardt, K. / Schaller, K. / Radovanovic, I. et al. | 2011
- S16
-
PP 92 Clinical and genetic characterization of dihydropyrimidine dehydrogenase deficiency in fluoropyrimidine-treated patients carrying the DPYD2A alleleDel Re, M. / Barbara, C. / Loupakis, F. / Michelucci, A. / Simi, P. / Bocci, G. / Di Paolo, A. / Cappuzzo, F. / Falcone, A. / Danesi, R. et al. | 2011
- S17
-
65 INVITED Evidence to Support Definitive Chemo-RadiotherapyDe Ruvsscher, D. et al. | 2011
- S17
-
PP 56 Suitability of advanced non-small cell lung cancer biopsies for prospective, multiple molecular analyses in clinical trialsFennell, D. / Nicolson, M. / Ferry, D. / OByrne, K. / Moore, S. / McErlean, S. / Kennedy, L. / Murray, N. / Das, M. / Kerr, K. et al. | 2011
- S18
-
PP 63 Integrating hypoxia and native conditions for immune complex formation in the serological proteome analysis (SERPA) to improve the detection of autoantibodies as cancer biomarkersGrandjean, M. / Defresne, F. / Guilbaud, C. / Raes, M. / Dieu, M. / Sermeus, A. / De Ridder, M. / Feron, O. et al. | 2011
- S18
-
67 INVITED Stage III-N2 Non-Small Cell Lung Cancer - Choice of Chemotherapy SchemesFelip, E. et al. | 2011
- S19
-
PP 6 The metabolic response using FDG/PET for predicting tumor response and prognosis after pre-operative chemoradiotherapy (CRT) in patients with locally recurrent rectal cancer (LRRC)Ikeda, M. / Sekimoto, M. / Handa, R. / Nishimura, J. / Takemasa, I. / Mizushima, T. / Yamamoto, H. / Doki, Y. / Mori, M. et al. | 2011
- S20
-
75 INVITED Differential and Unexpected Impact of Adjuvant Versus Metastatic Antiangiogenic TherapyKerbel, R. et al. | 2011
- S20
-
PP 71 `Other' (non-activating, non-T790M) EGFR mutations and their clinical implications collected from various Tarceva trials in NSCLCKlughammer, B. / Spleiss, O. et al. | 2011
- S21
-
PP 10 Biomarker discovery by pharmacological studies in a population based tumor model for VEGFR inhibitorsLin, J. / Feng, J. / Bin, F. / Xiaojian, S. / Richard, N. / Brooke, E. / Slichenmyer, W. / Chiu, M. I. / Robinson, M. O. et al. | 2011
- S21
-
80 INVITED The Experience of Living With a PEGMartin, L. et al. | 2011
- S22
-
86 INVITED Novel Designs and Alternate Endpoints for New Drug StudiesDittrich, C. et al. | 2011
- S22
-
PP 11 Correlation between both serum osteopontin/osteonectin and bone remodelling parameters, inflammatory/metabolic variables and survival in metastatic cancer patients with tumors at different sitesMantovani, G. / Madeddu, C. / Astara, G. / Demurtas, L. / Antoni, G. / Serpe, R. / Ruggiero, V. et al. | 2011
- S23
-
PP 94 Polyamine Transport System (PTS) activity and hijacking in cancer cells: new option in Head and Neck tumors treatment with the polyamine-containing drug candidate F14512Meignan, S. / Mouawad, F. / Dewitte, A. / Bertheau, C. / Wattez, N. / Lartigau, E. / Chevalier, D. / Bailly, C. / Lansiaux, A. et al. | 2011
- S23
-
91 INVITED Update CTLA-4 Blockade Using Ipilimumab as First Line and Second Line Therapy for Advanced MelanomaWolchok, J. D. et al. | 2011
- S23
-
Radiotherapy in patients with metastatic breast cancerBudach, W. et al. | 2011
- S24
-
PP 57 Interaction of 4-demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) with melanoma melanin metabolism and cell deathMorgan, L. / Benes, E. / Rodgers, A. / Jursic, B. / Struck, R. / Waud, W. / Weiner, R. / Ware, M. / Friedlander, P. et al. | 2011
- S25
-
101 INVITED Soft-tissue SarcomasChisholm, J. C. et al. | 2011
- S26
-
PP 41 Anticancer potential of Datura inoxia extract against cervical cancer HeLa cellsPandey, M. / Saraswati, S. et al. | 2011
- S27
-
110 INVITED Image-Guided Radiation Therapy - From Current Concept to Future PerspectivesJaffray, D. et al. | 2011
- S28
-
Role of hormonal manipulations in patients with hormone-sensitive metastatic breast cancerBodmer, A. / Castiglione-Gertsch, M. et al. | 2011
- S28
-
PP 102 Gene expression profiles obtained from mouse hair, xenograft tumor and ex vivo human scalp hair to determine the effects of drug response following treatment with an EGFR inhibitorReed, B. / Grimes, E. / Mefo, T. / Harrison, E. / Meyer-Turkson, L. / Miele, G. / Brady, G. et al. | 2011
- S28
-
114 INVITED Translational Aspects of Hypoxia ModificationHoskin, P. J. et al. | 2011
- S30
-
PP 60 Targeting hyaluronan in tumor stroma. Interim translational and biomarker evaluations of pegylated hyaluronidase (PEGPH20) in animal models and patients with advanced solid tumorsDychter, S. / Ramanathan, R. / Infante, J. / Rosen, L. / Von Hoff, D. / Shepard, M. / Jiang, P. / Maneval, D. / Selvam, P. / Frost, G. et al. | 2011
- S31
-
128 INVITED Melanoma Therapy - Realising the Potential in Targeted TherapyFlaherty, K. et al. | 2011
- S31
-
PP 76 Biomarker discovery using multiplexed in solution proximity extension assays: a case-control study for early detection of colorectal cancerThorsen, S. B. / Lundberg, M. / Assarsson, E. / Gee, N. / Nielsen, B. S. / Christensen, I. J. / Nielsen, H. J. / Brunner, N. / Stenvang, J. / Fredriksson, S. et al. | 2011
- S32
-
133 INVITED Diffuse Large Cell Lymphoma (DLCL)Rosenwald, A. et al. | 2011
- S32
-
PP 39 Multi-determinants analysis of molecular alterations as predictor of resistance to cetuximab in metastatic colorectal cancerUlivi, P. / Passardi, A. / Capelli, L. / Chiadini, E. / Bravaccini, S. / Valgiusti, M. / Scarpi, E. / Molinari, C. / Casadio, V. / Zoli, W. et al. | 2011
- S33
-
136 INVITED Quality Assurance Through Outcome Registration in Colorectal Cancer - an ECCO Initiative for Europevan de Velde, C. et al. | 2011
- S33
-
PP 30 Prospective comparison of Recurrence Score, uPA/PAI-1, central grade and molecular subtyping in early breast cancer: first results from the WSG-Plan B trial (interim analysis)Wuerstlein, R. / Gluz, O. / Kreipe, H. / Kates, R. / Degenhardt, T. / Liedtke, C. / Shak, S. / Nitz, U. / Harbeck, N. et al. | 2011
- S34
-
140 INVITED Clinical Proteomics in the Early Detection of Breast CancerCelis, J. et al. | 2011
- S36
-
149 INVITED Molecular Pathways in Radiation FibrosisVozenin-Brotons, M. et al. | 2011
- S37
-
153 INVITED How Radical Should Surgery Be?Mariette, C. / Piessen, G. et al. | 2011
- S37
-
Author index| 2011
- S38
-
157 INVITED Cross-over in Oncology Clinical Trials - Statistical IssuesSargent, D. et al. | 2011
- S38
-
The role of chemotherapy and targeted agents in patients with metastatic breast cancerJohnston, S. R. et al. | 2011
- S39
-
162 INVITED MR-response Criteria in NeurooncologyBendszus, M. et al. | 2011
- S40
-
167 INVITED Energy Balance Including Physical Activity Influence Breast and Colon Carcinogenesis - Results From Recent StudiesThune, I. et al. | 2011
- S41
-
172 INVITED `Spread of Excellence' (Dissemination) Activities of the European Network of Excellence for Cancer Research in Children and Adolescents (ENCCA)Pritchard-Jones, K. et al. | 2011
- S41
-
Disclosures| 2011
- S43
-
185 INVITED Eurocancoms Project - Multidisciplinary Guidelines Where are we?Schrijvers, D. et al. | 2011
- S44
-
188 INVITED Novel Molecular Targeted Agents in NSCLC (Beyond EGFR, ALK and IGFR1)Soria, J. C. et al. | 2011
- S45
-
193 INVITED A Future Research Agenda to Improve Pain Control Through Collaborative EffortsBuche, D. et al. | 2011
- S46
-
198 INVITED The Future of Radiation Therapy in Comprehensive Cancer CareJohansson, S. et al. | 2011
- S48
-
208 INVITED Radiation Oncology as a Clinical Specialty in a Multidisciplinary Environment: QUO VADIS?Perez, C. et al. | 2011
- S50
-
214 INVITED The EAU Guidelines on Testicular CancerLaquna, M. et al. | 2011
- S51
-
215 INVITED What is New in the Systemic Treatment of Urological Malignancies| 2011
- S51
-
216 INVITED Past Present and Future of Geriatric Oncology - a "Time Bomb"Audisio, R. et al. | 2011
- S52
-
219 INVITED Cancer Clinical Trials in the Elderly - Are we Ageist?Reed, M. et al. | 2011
- S52
-
Neoadjuvant chemotherapy for non-/resectable metastasesFolprecht, G. et al. | 2011
- S53
-
224 INVITED Age, Screening and High Risk Groups SurveillanceWilson, R. et al. | 2011
- S54
-
229 INVITED Tumour Suppressor Networks: Lessons From p53Oren, M. / Aylon, Y. / Shema, E. / Fuchs, G. et al. | 2011
- S55
-
235 INVITED Molecular Imaging for Response Monitoring in Esophageal CancerLordick, F. et al. | 2011
- S57
-
244 INVITED Prostate Cancer Patients - What do They Really Need?Denis, L. / Briers, E. / Boeye, F. / Van Daele, H. / Dourcy-Belle-Rose, B. / Costa, A. et al. | 2011
- S58
-
248 INVITED How to Reverse the Resistance to TrastuzumabAndre, F. / Campone, M. et al. | 2011
- S59
-
253 INVITED Tailored Adjuvant Chemotherapy According to Pathological Response (?)Scheithauer, W. et al. | 2011
- S61
-
264 INVITED Addressing Consequences of Treatment - the Role of RehabilitationRobb, K. et al. | 2011
- S61
-
Surgery of the primary in stage IV colorectal cancer with unresectable metastasesVerhoe, C. / de Wilt, J. H. / Burger, J. W. / Verheu, H. M. / Koopman, M. et al. | 2011
- S62
-
268 INVITED Personalised Therapy in Lung CancerRosell, R. et al. | 2011
- S63
-
272 INVITED Optimising Treatment in Gliomas - TranslationalBjerkviq, R. / Keunen, O. / Niclou, S. R. et al. | 2011
- S64
-
277 INVITED IGF1R Targeting in Non-sarcoma Pediatric MalignanciesGeoerqer, B. et al. | 2011
- S65
-
284 INVITED Active Surveillance| 2011
- S66
-
290 INVITED Surgical Resection of Hilar and Intrahematic CholangiocarcinomaFarges, O. et al. | 2011
- S67
-
297 INVITED Image-guided Adaptative Brachytherapy (IGABT) and External Radiotherapy in Patients With Cervix CancerHaie-Meder, C. / Mazeron, R. / Dumas, I. / Lhomme, C. / Morice, P. et al. | 2011
- S67
-
The treatment of patients with low tumour burden and/or slow growing diseaseMaughan, T. S. et al. | 2011
- S68
-
301 INVITED ALK in NSCLC - Paving the Way for Oncogene-directed TherapyDoebele, R. et al. | 2011
- S69
-
306 INVITED Surgical Management of Primary Retroperitoneal Sarcomas: Improving OutcomesStrauss, P. C. / Hayes, A. J. / Thomas, J. M. et al. | 2011
- S71
-
316 INVITED Breast Conservation in Young Women With Early Breast CancerVeronesi, U. et al. | 2011
- S72
-
319 INVITED Neoadjuvant Treatment in Colon CancerSobrero, A. / Di Benedetto, M. et al. | 2011
- S74
-
332 INVITED Registration-Directed Co-Development of Biomarkers and TherapeuticsBuller, R. / Sakul, H. / Wilner, K. / Selaru, N. / Taylor, I. / Ho, S. / Donnelly, E. et al. | 2011
- S76
-
Re-challenge and the concept of lines of therapy in metastatic colorectal cancerde Gramont, A. et al. | 2011
- S76
-
340 INVITED Who Needs a (new) Histopathological And/or Molecular Classification?Dei Tos, A. et al. | 2011
- S78
-
353 INVITED Immunotherapy of Paediatric MalignanciesMinard-Colin, V. / Valteau-Couanet, D. / Zitvogel, L. et al. | 2011
- S79
-
358 INVITED The Point of View of a StatisticianCollette, L. et al. | 2011
- S80
-
363 INVITED Non-compliance in the Adjutant Endocrine Treatment of Women With Breast CancerHadji, P. P. et al. | 2011
- S82
-
372 INVITED New Molecular Targeted TherapiesLloveL, J. et al. | 2011
- S83
-
378 INVITED New Directions in Angiogenesis TherapyJavson, G. C. et al. | 2011
- S84
-
385 INVITED The Role of BRAF and KRAS in Melanoma ProgressionMarais, R. et al. | 2011
- S86
-
395 INVITED How to Follow up the Acute and the Late Toxicity With New Emerging Therapies?Liao, Z. X. et al. | 2011
- S88
-
Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancerVergote, I. / Amant, F. / Kristensen, G. / Ehlen, T. / Reed, N. S. / Casado, A. et al. | 2011
- S88
-
402 INVITED Alternative Surgical Resections for Lobectomy| 2011
- S89
-
409 INVITED Dying Well - Challenges in Acute Oncology SettingsLarkin, P. et al. | 2011
- S90
-
414 INVITED Radiotherapy as Adjuvant Treatment to Surgery or as Definitive Treatment?Budach, V. et al. | 2011
- S93
-
First line therapy: have we made any improvement?Bookman, M. A. et al. | 2011
- S95
-
803 ORAL Analysis of Blood Plasma Factors in the AVITA Phase III Randomized Study of Bevacizumab (bev) With Gemcitabine-Erlotinib (GE) in Patients (pts) With Metastatic Pancreatic Cancer (mPC)Van Cutsem, E. / Jayson, G. / Dive, C. / Dilba, P. / de Haas, S. / Wild, N. / Delmar, P. / Scherer, S. J. et al. | 2011
- S97
-
1003 ORAL Crosstalk Between Homeobox Proteins and Polycomb Complexes in P16INK4a RegulationGil, J. / Popov, J. / Martin, N. / Raguz, S. / Li, S. / Walsh, M. et al. | 2011
- S98
-
1006 ORAL Prognostic Factors for Progression-free Survival (PFS), Overall Survival (OS), and Long-term OS (LT-OS) With Sunitinib in 1,059 Patients, Treated on Clinical Trials, With Metastatic Renal Cell Carcinoma (mRCC)Motzer, R. J. / Escudier, B. / Bukowski, R. / Rini, B. I. / Hutson, T. E. / Barrios, C. H. / Lin, X. / Fly, K. / Matczak, E. / Gore, M. E. et al. | 2011
- S99
-
1009 POSTER Mammary Gland Tumour Formation in Conditional Transgenic Mice Expressing GLI1Norum, J. H. / Kasper, M. / Jaks, V. / Toftgard, R. et al. | 2011
- S100
-
1012 POSTER Activation of Nuclear Factor Kappa B and Induction of Migrationinhibitory Factor in Tumours by Surgical Stress of Laparotomy Versus Carbon Dioxide Pneumoperitoneum in a Nude Mice ModelAmin, A. T. / Kitano, S. / Shiraishi, N. / Ninomiya, S. / Tajima, M. / Inomata, M. et al. | 2011
- S101
-
1016 POSTER Are CD133 Positive Cells From Esophagus Ascites Cancer Stem Cells?Stoeltinq, S. / Hinz, S. / Ungefroren, H. / Lehnert, H. / Gieseler, F. et al. | 2011
- S102
-
1020 POSTER Detection of Circulating Tumour Cells (CTCs) in Gastrointestinal Tumours Using Reverse Transcriptase-polymerase Chain Reaction (RT-PCR) MethodKucukyildirim, S. / Erdem, B. / Polat, Z. / Mergen, H. et al. | 2011
- S104
-
1028 POSTER Gabexate Mesilate Induces the Apoptosis of HepG2cellsOzeki, T. et al. | 2011
- S104
-
Clinical trials and decision-making strategies for optimal treatment of relapsed ovarian cancerLedermann, J. A. / Raja, F. A. et al. | 2011
- S105
-
1031 POSTER Protein-bound Polysaccharide From Phellinus Linteus Inhibits Tumour Growth, Invasion, and Angiogenesis Through Inhibition of Wnt/b-catenin Signaling in SW480 Human Colon Cancer CellsLim, K. / Song, K. S. / Li, G. / Kim, T. D. / Jing, K. / Seo, S. B. / Yoo, J. K. / Park, H. D. / Hwang, B. D. / Yoon, W. H. et al. | 2011
- S106
-
1035 POSTER Genome-wide Promoter and CpG Island DNA Methylation Screening Identifies Novel Prognostic Markers and Distinct Pathway in Rectal CancerLeonq, K. J. / Wei, W. / Tannahill, L. A. / Caldwell, G. M. / James, J. / Jones, C. E. / Morton, D. G. / Bach, S. R. / Matthews, G. M. et al. | 2011
- S108
-
1043 POSTER Lysyl TRNa Synthethase - Ap4a Pathway - a Possible Role in CancerNechushtan, H. / Schnall, G. / Razin, E. / Ofir-Birin, Y. / Ochayon, H. et al. | 2011
- S110
-
1050 POSTER Copy-neutral Loss of Heterozygosity at the P53 Locus in Esophageal Squamous Cell Carcinomas Associated With p53 MutationsSaeki, H. / Kitao, H. / Ando, K. / Egashira, A. / Oki, E. / Ohga, T. / Morita, M. / Emi, Y. / Kakeji, Y. / Maehara, Y. et al. | 2011
- S111
-
1054 POSTER 17beta-estradiol Signaling via Estrogen Receptor Alpha-36 Enhances Survival and Invasion of ERalpha-negative Breast Cancer CellsChaudhri, R. A. / Cuenca, N. / Hadadi, A. / Schwartz, Z. / Boyan, B. D. et al. | 2011
- S113
-
1061 POSTER Foxo3a Loss is a Key Event in High-grade Pelvic Serous CarcinogenesisLevanon, K. / Hirsch, M. / Miron, A. / Ligon, A. / Birrer, M. / Drapkin, R. et al. | 2011
- S114
-
1065 POSTER An in Vitro Comparative Study of Fulvestrant and Tamoxifen in Breast Cancer CellsGiannopoulou, E. / Lvmperatou, D. / Koutras, A. / Kalofonos, H. P. et al. | 2011
- S116
-
1072 POSTER Silencing of DREV1 Promotes Cell Proliferation and Invasion in Lung AdenocarcinomaHarun, R. / Hazir, N. S. / Pang, J. C. / Rose, I. M. et al. | 2011
- S116
-
The role of targeted therapy in ovarian cancerBanerjee, S. / Kaye, S. et al. | 2011
- S117
-
1076 POSTER Overexpression of Calreticulin in Malignant and Benign Breast Tumours: Relationship to the Humoral ImmunityEric-Nikolic, A. / Milovanovic, Z. / Sanchez, D. / Pekarikova, A. / Dzodic, R. / Matic, I. / Tuckova, L. / Jevric, M. / Buta, M. et al. | 2011
- S118
-
1079 POSTER Changes in Proteasome Pool in Human Papillary Thyroid Carcinoma DevelopmentKarpova, Y. / Astakhova, T. / Sharova, N. et al. | 2011
- S119
-
1083 POSTER The Effects of Heparan Sulfate Mimetic RGTA-OTR4120 on Radiation-induced Salivary Gland Dysfunction in MiceSpieqelberq, L. / Djasim, U. M. / van Neck, J. W. / Wolvius, E. B. / van der Wal, K. G. et al. | 2011
- S120
-
1087 POSTER The Synergic Effect of CKD-516 to Conventional ChemotherapyKim, S. / Yoon, S. A. / Lee, D. H. / Shin, H. J. / Lim, I. T. / Yu, H. S. / Kim, D. H. / Kim, S. K. / Lee, S. S. et al. | 2011
- S122
-
1094 POSTER EpCAM+ Tumour Cells Are Frequently Detected in Malignant Ascites Samples- Results From a Randomized Phase 1Mb CASIMas StudyMartinius, H. / Biesterfeld, S. / Seitz-Merwald, I. / Hennig, M. / Seimetz, D. / Booking, A. et al. | 2011
- S124
-
1101 POSTER Identification of KRas Mutational Polymorphism by Molecular Analysis Using High-resolution Melting System in a Large MCRC Mexican SampleVega, H. A. / Romero-Garcia, P. / Silva, J. A. / Villalobos-Valencia, R. / Vazquez-Rivera, V. M. / Ruiz-Calzada, H. / Lopez-Yafiez, A. / Cortes-Esteban, P. / Calderillo-Ruiz, G. / Ruiz-Garcia, E. et al. | 2011
- S126
-
1108 POSTER DEAD/H (Asp-Glu-Ala-Asp/His) Box Polypeptide 3, X-linked is a CD133+ Tumour-specific Protein and Induces Antitumour ImmunityIchikawa, K. / Kagamu, H. / Koshio, J. / Saida, Y. / Miura, S. / Watanabe, S. / Tanaka, J. / Yoshizawa, H. / Narita, I. et al. | 2011
- S127
-
1111 POSTER Adoptive T Cell Therapy Enhances the Secretion Ability of Cytokines to Th1 and Reduces the Number of TregsSakamoto, N. / Kokura, S. / Ishikawa, T. / Matsumoto, T. / Uno, K. / Naito, Y. / Yoshikawa, T. et al. | 2011
- S128
-
1115 POSTER Impaired Autophagy Contributes to Resistance to Metronomic Cyclophosphamide ChemotherapyChow, A. / Emmeneqqer, U. et al. | 2011
- S129
-
1119 POSTER Influence of Soluble CD40 Ligand on Colorectal Cancer Cells: a Flow Cytometric StudyTorchio, M. / Comolli, G. / Chiesa, A. / Mazzini, G. / Danova, M. et al. | 2011